EurekaMag PDF full texts Chapter 43,928

Winne, D. 1971: Pharmacokinetics of absorption during perfusion of an intestinal loop with variable blood flow. Naunyn-Schmiedebergs Archiv für Pharmakologie 268(4): 417-433

Beckett, A.H.; Salmon, J.A. 1972: Pharmacokinetics of absorption, distribution and elimination of fenfluramine and its main metabolite in man. Journal of Pharmacy and Pharmacology 24(2): 108-114

van Rossum, J.M. 1968: Pharmacokinetics of accumulation. Journal of Pharmaceutical Sciences 57(12): 2162-2165

Roux, A.; Flouvat, B.; Chau, N.P.; Letac, B.; Lucsko, M. 1980: Pharmacokinetics of acebutolol after intravenous bolus administration. British Journal of Clinical Pharmacology 9(2): 215-217

Tse, F.L.; Welling, P.G. 1980: Pharmacokinetics of acetylmethadols I: gas-liquid chromatographic determination of L-alpha-acetylmethadol and its major metabolites in plasma. Biopharmaceutics and Drug Disposition 1(4): 203-209

Miller, M.J.; Carter, D.E.; Sipes, I.G. 1982: Pharmacokinetics of acrylamide in Fisher-344 rats. Toxicology and Applied Pharmacology 63(1): 36-44

Békefi, E.; Bozzay, J.; Dávid, A.; Rusznák, I. 1982: Pharmacokinetics of active ingredients liberated according to apparently zero-order kinetics from peroral preparations. Acta Pharmaceutica Hungarica 52(5): 200-216

De Miranda, P.; Blum, M.R. 1983: Pharmacokinetics of acyclovir after intravenous and oral administration. Journal of Antimicrobial ChemoTherapy 12 Suppl B: 29-37

Whitley, R.J.; Blum, M.R.; Barton, N.; de Miranda, P. 1982: Pharmacokinetics of acyclovir in humans following intravenous administration. a model for the development of parenteral antivirals. American Journal of Medicine 73(1a): 165-171

Benjamin, R.S. 1974: Pharmacokinetics of adriamycin (NSC-123127) in patients with sarcomas. Cancer ChemoTherapy Reports 58(2): 271-273

Robert, J.; Illiadis, A.; Hoerni, B.; Cano, J.P.; Durand, M.; Lagarde, C. 1982: Pharmacokinetics of adriamycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term response. European Journal of Cancer and Clinical Oncology 18(8): 739-745

Allen, J.G.; Lees, L.J. 1980: Pharmacokinetics of alafosfalin, alone and in combination with cephalexin, in humans. Antimicrobial Agents and ChemoTherapy 17(6): 973-979

Marriner, S.E.; Bogan, J.A. 1980: Pharmacokinetics of albendazole in sheep. American Journal of Veterinary Research 41(7): 1126-1129

Couzigou, P.; Fleury, B.; Bourjac, M.; Betbeder, A.M.; Vinçon, G.; Richard-Molard, B.; Albin, H.; Amouretti, M.; Béraud, C. 1984: Pharmacokinetics of alcohol after 3-hour intravenous infusion with and without cimetidine in 10 healthy non-alcoholic subjects. Gastroenterologie Clinique et Biologique 8(2): 103-108

Stephens, I.D.; Ho, P.C.; Holloway, A.M.; Bourne, D.W.; Triggs, E.J. 1984: Pharmacokinetics of alcuronium in elderly patients undergoing total hip replacement or aortic reconstructive surgery. British Journal of Anaesthesia 56(5): 465-471

Camu, F.; Gepts, E.; Rucquoi, M.; Heykants, J. 1982: Pharmacokinetics of alfentanil in man. Anesthesia and Analgesia 61(8): 657-661

Bromet, N.; Aubert, Y.; Baune, A.; Courte, S.; Guillaudeux, J. 1980: Pharmacokinetics of almitrine. Revue Francaise des Maladies Respiratoires 8(6): 569-576

Bromet, N.; Courte, S.; Aubert, Y.; Baune, A.; Balem, M.P.; du Vignaud, P. 1983: Pharmacokinetics of almitrine bismesylate: studies in patients. European Journal of Respiratory Diseases. Suppl 126: 363-375

Schrader, K.; Brass, H.; Renner, D. 1971: Pharmacokinetics of alpha-methyldopa in kidney failure. Klinische Wochenschrift 49(24): 1329-1334

Abernethy, D.R.; Greenblatt, D.J.; Divoll, M.; Shader, R.I. 1983: Pharmacokinetics of alprazolam. Journal of Clinical Psychiatry 44(8 Pt 2): 45-47

Horadam, V.W.; Sharp, J.G.; Smilack, J.D.; McAnalley, B.H.; Garriott, J.C.; Stephens, M.K.; Prati, R.C.; Brater, D.C. 1981: Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Annals of Internal Medicine 94(4 Part 1): 454-458

Neu, H.C.; Srinivasan, S.; Francke, E.L.; Ortiz-Neu, C.; Christenson, J.G. 1983: Pharmacokinetics of amdinocillin and pivamdinocillin in normal volunteers. American Journal of Medicine 75(2a): 60-64

Meyers, B.R.; Jacobson, J.; Masci, J.; Srulevitch, E.; Hirschman, S.Z. 1983: Pharmacokinetics of amdinocillin in healthy adults. Antimicrobial Agents and ChemoTherapy 23(6): 827-830

Traut, M.; Brode, E. 1981: Pharmacokinetics of amezinium in man. Arzneimittel-Forschung 31(9a): 1605-1615

Traut, M.; Brode, E.; Neumann, B.; Kummer, H. 1981: Pharmacokinetics of amezinium in rat and dog. Arzneimittel-Forschung 31(9a): 1594-1604

Yasuhara, H.; Kobayashi, S.; Sakamoto, K.; Kamijo, K. 1982: Pharmacokinetics of amikacin and cephalothin in bedridden elderly patients. Journal of Clinical Pharmacology 22(8-9): 403-409

Vincent, P.; Izard, D.; Colombel, J.F.; Husson, M.O.; Cortot, A.; Paris, J.C.; Leclerc, H. 1985: Pharmacokinetics of amikacin in ascitic cirrhotic patients. Therapie 40(6): 441-446

Padovani, E.M.; Pistolesi, C.; Fanos, V.; Messori, A.; Martini, N. 1993: Pharmacokinetics of amikacin in neonates. Developmental Pharmacology and Therapeutics 20(3-4): 167-173

Brenner, B.E. 1980: Pharmacokinetics of aminophylline. Annals of Emergency Medicine 9(11): 599-600

Anastasiou-Nana, M.; Levis, G.M.; Moulopoulos, S. 1982: Pharmacokinetics of amiodarone after intravenous and oral administration. International Journal of Clinical Pharmacology Therapy and Toxicology 20(11): 524-529

Riva, E.; Gerna, M.; Latini, R.; Giani, P.; Volpi, A.; Maggioni, A. 1982: Pharmacokinetics of amiodarone in man. Journal of Cardiovascular Pharmacology 4(2): 264-269

Fortunati, M.T.; Morandi, F.; Santarone, M.; Saveri, C.; Forgione, N.; Marini, G.; Cozzi, A. 1983: Pharmacokinetics of amiodarone in one case of acute oral intoxication. Giornale Italiano di Cardiologia 13(5): 385-388

Riva, E.; Gerna, M.; Neyroz, P.; Urso, R.; Bartosek, I.; Guaitani, A. 1982: Pharmacokinetics of amiodarone in rats. Journal of Cardiovascular Pharmacology 4(2): 270-275

Henry, J.F.; Altamura, C.; Gomeni, R.; Hervy, M.P.; Forette, F.; Morselli, P.L. 1981: Pharmacokinetics of amitriptyline in the elderly. International Journal of Clinical Pharmacology Therapy and Toxicology 19(1): 1-5

Kamimura, H.; Sasaki, H.; Kawamura, S. 1984: Pharmacokinetics of amosulalol, an alpha, beta-adrenoceptor blocker, in rats, dogs and monkeys. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 14(8): 613-620

Zarowny, D.; Ogilvie, R.; Tamblyn, D.; MacLeod, C.; Ruedy, J. 1974: Pharmacokinetics of amoxicillin. Clinical Pharmacology and Therapeutics 16(6): 1045-1051

Adam, D.; de Visser, I.; Koeppe, P. 1982: Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrobial Agents and ChemoTherapy 22(3): 353-357

Adam, D.; Koeppe, P.; Heilmann, H.D. 1983: Pharmacokinetics of amoxicillin and flucloxacillin following the simultaneous intravenous administration of 4 g and 1 g, respectively. Infection 11(3): 150-154

Arancibia, A.; Drouguett, M.T.; Fuentes, G.; González, G.; González, C.; Thambo, S.; Palombo, G. 1982: Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function. International Journal of Clinical Pharmacology Therapy and Toxicology 20(10): 447-453

Chow, H.H.; Wu, Y.; Mayersohn, M. 1995: Pharmacokinetics of amphotericin B in rats as a function of dose following constant-rate intravenous infusion. Biopharmaceutics and Drug Disposition 16(6): 461-473

Modr, Z.; Dvorácek, K. 1970: Pharmacokinetics of ampicillin and hetacillin. Review of Czechoslovak Medicine 16(2): 84-95

Danilova, V.I.; Garsheva, G.B.; Marisenko, G.P. 1982: Pharmacokinetics of ampicillin in children with respiratory infections. Antibiotiki 27(12): 51-53

Iarmolinskii, I.S.; Vasina, T.A.; Goriainov, V.A. 1971: Pharmacokinetics of ampicillin in patients with kidney allograft. Antibiotiki 16(7): 661-663

Schreiner, A.; Bergan, T.; Hellum, K.B.; Digranes, A. 1981: Pharmacokinetics of ampicillin in serum and in dermal suction blisters after oral administration of bacampicillin. Reviews of Infectious Diseases 3(1): 125-131

Yoshioka, H.; Takimoto, M.; Riley, H.D. 1974: Pharmacokinetics of ampicillin in the newborn infant. Journal of Infectious Diseases 129(4): 461-464

Doluisio, J.T.; LaPiana, J.C.; Dittert, L.W. 1971: Pharmacokinetics of ampicillin trihydrate, sodium ampicillin, and sodium dicloxacillin following intramuscular injection. Journal of Pharmaceutical Sciences 60(5): 715-719

Nishimura, K.; Nozaki, Y.; Yoshimi, A.; Nakamura, S.; Kitagawa, M.; Oketani, T.; Kakeya, N.; Kitao, K. 1983: Pharmacokinetics of an ampicillin suppository (KS-R1) in mice, rats and rabbits. Japanese Journal of Antibiotics 36(7): 1683-1691

Medgyesi, G.; Medgyesi, P. 1967: Pharmacokinetics of an intramuscularly administered drug. Die Pharmazie 22(5): 253-258

Brooks, S.G.; Christie, R.B.; Roche, J.; Fairhead, A.P.; Muirhead, D.; Townsend, H.A.; Shaw, H.L. 1984: Pharmacokinetics of an oral frusemide/amiloride combination tablet. Current Medical Research and Opinion 9(2): 141-146

Bertouch, J.V.; Maycock, S.; Harrington, B.; Brooks, P.M. 1983: Pharmacokinetics of an osmotically controlled delivery indomethacin preparation in normal volunteers. Clinical and Experimental Pharmacology and Physiology 10(4): 411-414

Lévy, R.H. 1980: Pharmacokinetics of anti-arrhythmics. 1. Fundamental principles. Archives des Maladies du Coeur et des Vaisseaux 73(10): 1223-1228

Lévy, R.H.; Lévy, S.; Bricaud, H. 1980: Pharmacokinetics of anti-arrhythmics. 2. Clinical applications. Archives des Maladies du Coeur et des Vaisseaux 73(10): 1229-1235

Ovusu, A.; Lur'e, A.A.; Petrov, O.E.; Ozeretskovskaia, N.N. 1984: Pharmacokinetics of anti-onchocerciasis preparations. 1. Suramin in standard and decreased doses. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 5: 40-44

Hitzenberger, G. 1971: Pharmacokinetics of antibiotics and its significance for therapy. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 77: 1412-1418

Nöschel, H.; Peiker, G.; Schröder, S.; Meinhold, P.; Müller, B. 1982: Pharmacokinetics of antibiotics and sulfanilamides in pregnancy and labor. Zentralblatt für Gynakologie 104(23): 1514-1518

Eben-Moussi, E.; van den Driessche, J. 1971: Pharmacokinetics of antibiotics in the human organism. Anesthesie Analgesie Reanimation 28(4): 671-687

Van Saanen, P. 1973: Pharmacokinetics of antibiotics. I. Constants of protein binding of antibiotics. Studii Si Cercetari de Medicina Interna 14(2): 167-174

Leucuţa, S. 1981: Pharmacokinetics of antibiotics: clinical applications. Revista de Medicina Interna Neurologe Psihiatrie Neurochirurgie Dermato-Venerologie. Medicina Interna 33(3): 207-214

Richens, A. 1980: Pharmacokinetics of anticonvulsant drugs. Acta Neurologica Scandinavica. Supplementum 80: 40-45

Rylance, G. 1984: Pharmacokinetics of anticonvulsant drugs and their dosage in childhood epilepsy. Recenti Progressi in Medicina 75(1): 51-65

Chadwick, D. 1983: Pharmacokinetics of anticonvulsants. British Journal of Hospital Medicine 30(6): 421-424

Tillement, J.P. 1973: Pharmacokinetics of antidepressive agents. Therapie 28(2): 249-268

Houin, G.; Barre, J.; Tillement, J.P. 1983: Pharmacokinetics of antiepileptic agents. Value of the measurement of plasma concentrations in the adjustment and monitoring of the treatment of epilepsy. Therapie 38(2): 179-185

Tokola, R.A.; Neuvonen, P.J. 1983: Pharmacokinetics of antiepileptic drugs. Acta Neurologica Scandinavica. Supplementum 97: 17-27

Knauf, H.; Mutschler, E. 1983: Pharmacokinetics of antihypertensive drugs in kidney and liver diseases. Mmw Munchener Medizinische Wochenschrift 125(45): 1037-1040

Norris, S.M.; Spyker, D.A. 1984: Pharmacokinetics of antimicrobial agents. Infection Control: Ic 5(2): 95-97

Fukaya, K.; Kitamoto, O. 1972: Pharmacokinetics of antimicrobial agents. Lividomycin. Japanese Journal of Antibiotics 25(6): 375-379

Skopnik, H.; Heimann, G. 1983: Pharmacokinetics of antimicrobial drugs in the cerebrospinal fluid. Pediatric Pharmacology 3(3-4): 313-320

Lur'e, A.A.; Ovusu, A.; Petrov, O.E.; Ozeretskovskaia, N.N. 1985: Pharmacokinetics of antionchocerciasis preparations. 2. the pharmacokinetics of suramin when administered simultaneously with diethylcarbamazine. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 5: 27-31

Kolpakov, A.R.; Kolpakov, M.A.; Panin, L.E. 1994: Pharmacokinetics of antipyrine and isoniazid in rats during dynamics of cold adaptation. Biulleten' Eksperimental'noi Biologii i Meditsiny 118(9): 279-280

Aanderud, L.; Bakke, O.M. 1983: Pharmacokinetics of antipyrine, paracetamol, and morphine in rat at 71 ATA. Undersea Biomedical Research 10(3): 193-201

Benker, G.; Reinwein, D. 1982: Pharmacokinetics of antithyroid drugs. Klinische Wochenschrift 60(11): 531-539

Krüger-Thiemer, E. 1968: Pharmacokinetics of antitubercular agents. Zeitschrift für Tuberkulose und Erkrankungen der Thoraxorgane 128(1): 218-227

Acocella, G. 1984: Pharmacokinetics of antitubercular agents in man. Minerva Medica 75(11): 561-563

Kislitsyna, N.A.; Kotova, N.I. 1981: Pharmacokinetics of antitubercular preparations in the caseous necrotic sites and foci of pulmonary tuberculosis patients. Problemy Tuberkuleza 10: 28-30

Zítková, L.; Janků, I.; Tousek, J.; Papezová, E.; Stastná, J. 1983: Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination. Czechoslovak Medicine 6(4): 202-217

Filov, V.A.; Kulik, G.I. 1983: Pharmacokinetics of antitumor drugs. Voprosy Onkologii 29(7): 3-13

Rovei, V.; Broquaire, M.; Tedeschi, G.; Thebault, J.J.; Sauvanet, J.P.; Larribaud, J. 1980: Pharmacokinetics of antrafenine after a single dose in the young adult. Therapie 35(4): 551-552

Sauvanet, J.P.; Rovei, V.; Guinebault, P.; Trocherie, S.; Memin, Y.; Gomeni, R.; Braithwaite, R.A.; Venet, R. 1980: Pharmacokinetics of antrafenine after single and repeated administration in aged patients. Therapie 35(4): 552-554

Pierre, J.; Chastre, J.; Gibert, C.; Bergogne-Berezin, E. 1983: Pharmacokinetics of apalcillin (PC 904). Study of penetration into bronchial secretions. Pathologie-Biologie 31(5): 323-327

Bergogne-Berezin, E.; Pierre, J.; Chastre, J.; Gibert, C.; Heinzel, G.; Akbaraly, J.P. 1984: Pharmacokinetics of apalcillin in intensive-care patients: study of penetration into the respiratory tract. Journal of Antimicrobial ChemoTherapy 14(1): 67-73

Akbaraly, J.P.; Brachet-Liermain, A.; Quentin, C.; Heinzel, G.; Guyot, M.; Coux, C.; Auzerie, J.; Bebear, C. 1984: Pharmacokinetics of apalcillin. Study of linearity. Pathologie-Biologie 32(5): 307-311

Lashev, L.D.; Mihailov, R. 1994: Pharmacokinetics of apramycin in Japanese quails. Journal of Veterinary Pharmacology and Therapeutics 17(5): 394-395

Campistron, G.; Guiraud, R.; Cros, J.; Pontagnier, H. 1983: Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat--III: Changes in the levels of amino acids in the plasma, liver and brain after simultaneous administration of arginine and aspartic acid. European Journal of Drug Metabolism and Pharmacokinetics 8(3): 281-286

Brunet, C.; Luyckx, M.; Cazin, M. 1982: Pharmacokinetics of arsenic trioxide in the mouse. Toxicological European Research. Recherche Europeenne en Toxicologie 4(4): 175-179

Löscher, W.; Jaeschke, G.; Keller, H. 1984: Pharmacokinetics of ascorbic acid in horses. Equine Veterinary Journal 16(1): 59-65

Roberts, M.S.; Rumble, R.H.; Wanwimolruk, S.; Thomas, D.; Brooks, P.M. 1983: Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease. European Journal of Clinical Pharmacology 25(2): 253-261

Van der Vijgh, W.J.; Majid, P.A.; de Feyter, P.J.; Wardeh, R.; van der Wall, E.E. 1980: Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris. International Journal of Clinical Pharmacology Therapy and Toxicology 18(9): 375-377

Frölich, J.C. 1984: Pharmacokinetics of atenolol in acute respiratory infection. Biopharmaceutics and Drug Disposition 5(2): 199

Riva, E.; Farina, P.L.; Sega, R.; Tognoni, G.; Bastain, W.; McAinsh, J. 1980: Pharmacokinetics of atenolol in hypertensive subjects with and without co-administration of chlorthalidone. European Journal of Clinical Pharmacology 17(5): 333-337

Flouvat, B.; Decourt, S.; Aubert, P.; Potaux, L.; Domart, M.; Goupil, A.; Baglin, A. 1980: Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis. British Journal of Clinical Pharmacology 9(4): 379-385

Kirch, W.; Köhler, H.; Mutschler, E.; Schäfer, M. 1981: Pharmacokinetics of atenolol in relation to renal function. European Journal of Clinical Pharmacology 19(1): 65-71

Ward, S.; Neill, E.A.; Weatherley, B.C.; Corall, I.M. 1983: Pharmacokinetics of atracurium besylate in healthy patients (after a single I.v. bolus dose). British Journal of Anaesthesia 55(2): 113-118

Ward, S.; Neill, E.A. 1983: Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure). British Journal of Anaesthesia 55(12): 1169-1172

Intoccia, A.P.; Flanagan, T.L.; Walz, D.T.; Gutzait, L.; Swagzdis, J.E.; Flagiello, J.; Hwang, B.Y.; Dewey, R.H.; Noguchi, H. 1982: Pharmacokinetics of auranofin in animals. Journal of Rheumatology. Suppl 8: 90-98

Ritch, A.E.; Perera, W.N.; Jones, C.J. 1982: Pharmacokinetics of azapropazone in the elderly. British Journal of Clinical Pharmacology 14(1): 116-119

Odlind, B.; Grefberg, N.; Hartvig, P.; Lindström, B.; Lönnerholm, G. 1981: Pharmacokinetics of azathioprine and 6-mercaptopurine: methodological aspects and preliminary results in uremic patients. Scandinavian Journal of Urology and Nephrology. Supplementum 64: 213-219

Bergan, T.; Sørensen, G. 1980: Pharmacokinetics of azidocillin in healthy adults. Arzneimittel-Forschung 30(12): 2185-2191

Modr, Z.; Dvorácek, K.; Janků, I.; Krebs, V. 1982: Pharmacokinetics of azlocillin. Casopis Lekaru Ceskych 121(5): 136-139

Naber, K.G.; Adam, D. 1983: Pharmacokinetics of azlocillin after discontinuous intravenous administration of high dose. Journal of Antimicrobial ChemoTherapy 11 Suppl B: 115-120

Fillastre, J.P.; Humbert, G.; Leroy, A.; Godin, M. 1984: Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients. Presse Medicale 13(13): 797-801

Leroy, A.; Humbert, G.; Fillastre, J.P. 1981: Pharmacokinetics of azlocillin in healthy subjects. Scandinavian Journal of Infectious Diseases. Supplementum 29: 49-54

Sitka, U.; Weingärtner, L.; Patsch, R.; Richter, I. 1980: Pharmacokinetics of azlocillin in neonates. ChemoTherapy 26(3): 171-176

Delgado, F.A.; Stout, R.L.; Whelton, A. 1983: Pharmacokinetics of azlocillin in normal renal function: single and repetitive dosing studies. Journal of Antimicrobial ChemoTherapy 11 Suppl B: 79-88

Leroy, A.; Humbert, G.; Godin, M.; Fillastre, J.P. 1980: Pharmacokinetics of azlocillin in subjects with normal and impaired renal function. Antimicrobial Agents and ChemoTherapy 17(3): 344-349

Drugeon, H.B.; Pannier, M.; Courtieu, A.L. 1984: Pharmacokinetics of azlocillin in the burn patient. Presse Medicale 13(13): 805-807

Federspil, P. 1982: Pharmacokinetics of azlocillin in the perilymph and otitis media. Zfa. Zeitschrift für Allgemeinmedizin 58(11): 649-650

Mihindu, J.C.; Scheld, W.M.; Bolton, N.D.; Spyker, D.A.; Swabb, E.A.; Bolton, W.K. 1983: Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction. Antimicrobial Agents and ChemoTherapy 24(2): 252-261

Barza, M.; McCue, M. 1983: Pharmacokinetics of aztreonam in rabbit eyes. Antimicrobial Agents and ChemoTherapy 24(4): 468-473

Craig, W.A. 1983: Pharmacokinetics of bacampicillin tablets in adults. Bulletin of the new York Academy of Medicine 59(5): 457-467

Josefsson, K.; Bergan, T.; Magni, L.; Pring, B.G.; Westerlund, D. 1982: Pharmacokinetics of bacmecillinam and pivmecillinam in volunteers. European Journal of Clinical Pharmacology 23(3): 249-252

Küng, K.; Wanner, M. 1994: Pharmacokinetics of baytril (enrofloxacin) in dogs. Schweizer Archiv für Tierheilkunde 136(10): 329-334

Borgström, L.; Johansson, C.G.; Larsson, H.; Lenander, R. 1981: Pharmacokinetics of bendroflumethiazide after low oral doses. Journal of Pharmacokinetics and Biopharmaceutics 9(4): 431-441

Schäfer-Korting, M.; Mutschler, E. 1982: Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazine. European Journal of Clinical Pharmacology 21(4): 315-323

Sato, A.; Nakajima, T.; Fujiwara, Y.; Hirosawa, K. 1974: Pharmacokinetics of benzene and toluene. Internationales Archiv für Arbeitsmedizin 33(3): 169-182

Greenblatt, D.J.; Divoll, M.; Abernethy, D.R.; Locniskar, A.; Shader, R.I. 1983: Pharmacokinetics of benzodiazepine hypnotics. Pharmacology 27(Suppl 2): 70-75

Coffey, B.; Shader, R.I.; Greenblatt, D.J. 1983: Pharmacokinetics of benzodiazepines and psychostimulants in children. Journal of Clinical Psychopharmacology 3(4): 217-225

Breimer, D.D.; Jochemsen, R.; von Albert, H.H. 1980: Pharmacokinetics of benzodiazepines. Short-acting versus long-acting. Arzneimittel-Forschung 30(5a): 875-881

Jochemsen, R.; Breimer, D.D. 1984: Pharmacokinetics of benzodiazepines: metabolic pathways and plasma level profiles. Current Medical Research and Opinion 8(Suppl 4): 60-79

Bergan, T. 1984: Pharmacokinetics of beta-lactam antibiotics. Scandinavian Journal of Infectious Diseases. Supplementum 42: 83-98

Modrić, B.; Kovarbasić, B. 1981: Pharmacokinetics of beta-methyl-digoxin in patients on dialysis. Vojnosanitetski Pregled 38(2): 88-92

Rameis, H.; Bonelli, J.; Waginger, H.; Hruby, K. 1981: Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver. Wiener Klinische Wochenschrift 93(18): 572-576

Petersen, M.C.; Nation, R.L.; McBride, W.G.; Ashley, J.J.; Moore, R.G. 1983: Pharmacokinetics of betamethasone in healthy adults after intravenous administration. European Journal of Clinical Pharmacology 25(5): 643-650

Belykh, A.G. 1983: Pharmacokinetics of bilignost in the normal liver and in experimental pathology. Farmakologiia i Toksikologiia 46(3): 105-108

Bottermann, P.; Gyaram, H.; Wahl, K.; Ermler, R.; Lebender, A. 1981: Pharmacokinetics of biosynthetic human insulin and characteristics of its effect. Diabetes Care 4(2): 168-169

Duhm, B.; Maul, W.; Medenwald, H.; Patzschke, K.; Wegner, L.A.; Oberste-Lehn, H. 1972: Pharmacokinetics of bis-phenyl-(2-chloro-phenyl)-1-imidazolyl-methane-( 14 C) following topical administration. Arzneimittel-Forschung 22(8): 1276-1280

Oken, M.M.; Crooke, S.T.; Elson, M.K.; Strong, J.E.; Shafer, R.B. 1981: Pharmacokinetics of bleomycin after im administration in man. Cancer Treatment Reports 65(5-6): 485-489

Mehnert, H. 1969: Pharmacokinetics of blood glucose lowering biguanide derivatives. Acta Diabetologica Latina 6(Suppl 1): 137-142

Krüger-Thiemer, E.; Bünger, P.; Seydel, J.K. 1969: Pharmacokinetics of blood glucose lowering sulfonamides. Acta Diabetologica Latina 6(Suppl 1): 74-104

Tanaka, K.; Pettinger, W.A. 1973: Pharmacokinetics of bolus potassium injections for cardiac arrhythmias. Anesthesiology 38(6): 587-589

Takada, K.; Asada, S.; Ichikawa, Y.; Sonoda, T.; Takahara, S.; Nagano, S.; Fukunishi, T. 1983: Pharmacokinetics of bredinin in renal transplant patients. European Journal of Clinical Pharmacology 24(4): 457-461

Kamath, B.L.; Gibson, T.P.; Look, Z.M.; McEntegart, C.M.; Comrie, E.B.; Yacobi, A. 1982: Pharmacokinetics of bretylium in dogs and the effect of hemoperfusion on elimination. Journal of Pharmaceutical Sciences 71(11): 1294-1296

Narang, P.K.; Adir, J.; Josselson, J.; Yacobi, A.; Sadler, J. 1980: Pharmacokinetics of bretylium in man after intravenous administration. Journal of Pharmacokinetics and Biopharmaceutics 8(4): 363-372

Raaflaub, J.; Speiser-Courvoisier, J. 1974: Pharmacokinetics of bromazepam in man. Arzneimittel-Forschung 24(11): 1841-1844

Rauws, A.G. 1983: Pharmacokinetics of bromide ion--an overview. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 21(4): 379-382

Jochemsen, R.; Wesselman, J.G.; Hermans, J.; van Boxtel, C.J.; Breimer, D.D. 1983: Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration. British Journal of Clinical Pharmacology 16(Suppl 2): 285s-290s

Evers, J.; Renner, E.; Bechtel, W.D. 1983: Pharmacokinetics of brotizolam in renal failure. British Journal of Clinical Pharmacology 16(Suppl 2): 309s-313s

Jochemsen, R.; Nandi, K.L.; Corless, D.; Wesselman, J.G.; Breimer, D.D. 1983: Pharmacokinetics of brotizolam in the elderly. British Journal of Clinical Pharmacology 16(Suppl 2): 299s-307s

Rey, E.; Barrier, G.; d'Athis, P.; de Lauture, D.; Richard, M.O.; Lirzin, J.P.; Sureau, C.; Olive, G. 1980: Pharmacokinetics of buflomedil after intravenous and oral administration. International Journal of Clinical Pharmacology Therapy and Toxicology 18(10): 437-441

Blake, D.W.; Bjorksten, A.; Dawson, P.; Hiscock, R. 1994: Pharmacokinetics of bupivacaine enantiomers during interpleural infusion. Anaesthesia and Intensive Care 22(5): 522-528

Findlay, J.W.; Van Wyck Fleet, J.; Smith, P.G.; Butz, R.F.; Hinton, M.L.; Blum, M.R.; Schroeder, D.H. 1981: Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects. European Journal of Clinical Pharmacology 21(2): 127-135

Arranz, M.A.; Pérez, M.I.; Sáiz-Vadillo, M.C.; Basagoiti, I.; Katarneh, S.M.; Ribas, B.; Cadórniga, R. 1984: Pharmacokinetics of cadmium-109 in blood and brain structures of the rat. Revista Espanola de Fisiologia 40(3): 365-370

Brazier, J.L.; Ritter, J.; Berland, M.; Khenfer, D.; Faucon, G. 1983: Pharmacokinetics of caffeine during and after pregnancy. Developmental Pharmacology and Therapeutics 6(5): 315-322

Hartmann, M.; Czok, G. 1980: Pharmacokinetics of caffeine in mice and its modification by ethanol. Zeitschrift für Ernahrungswissenschaft 19(3): 215-227

Ryszka, F.; Dolińska, B.; Gawroński, M.; Szulc, B. 1994: Pharmacokinetics of calcitonin and osteocalcin marked 125J in rats. Die Pharmazie 49(10): 783-784

Storstein, L.; Larsen, A.; Midtbø, K.; Saevareid, L. 1984: Pharmacokinetics of calcium blockers in patients with renal insufficiency and in geriatric patients. Acta Medica Scandinavica. Supplementum 681: 25-30

Krause, W.; Karras, J.; Seifert, W. 1983: Pharmacokinetics of canrenone after oral administration of spironolactone and intravenous injection of canrenoate-K in healthy man. European Journal of Clinical Pharmacology 25(4): 449-453

Gengo, F.M.; Schentag, J.J.; Jusko, W.J. 1984: Pharmacokinetics of capacity-limited tissue distribution of methicillin in rabbits. Journal of Pharmaceutical Sciences 73(7): 867-873

Singhvi, S.M.; Peterson, A.E.; Ross, J.J.; Shaw, J.M.; Keim, G.R.; Migdalof, B.H. 1981: Pharmacokinetics of captopril in dogs and monkeys. Journal of Pharmaceutical Sciences 70(10): 1108-1112

Frey, H.H.; Löscher, W. 1980: Pharmacokinetics of carbamazepine in the dog. Archives Internationales de Pharmacodynamie et de Therapie 243(2): 180-191

Neussel, H.; Olbing, H. 1972: Pharmacokinetics of carbenicillin in children following intramuscular injection. Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 5(4): 444-449

Morehead, C.D.; Shelton, S.; Kusmiesz, H.; Nelson, J.D. 1972: Pharmacokinetics of carbenicillin in neonates of normal and low birth weight. Antimicrobial Agents and ChemoTherapy 2(4): 267-271

Hoffman, T.A.; Cestero, R.; Bullock, W.E. 1970: Pharmacokinetics of carbenicillin in patients with hepatic and renal failure. Journal of Infectious Diseases 122(Suppl): s75-77

Iakovlev, V.P.; Livshits, A.V.; Marshak, A.M. 1971: Pharmacokinetics of carbenicillin in patients with traumatic lesions of the spinal cord. Antibiotiki 16(5): 469-472

Vlietstra, R.E. 1980: Pharmacokinetics of cardiovascular drugs. Cardiovascular Clinics 10(3): 255-270

Reich, S.D.; Fandrich, S.E.; Finkelstein, T.T.; Schurig, J.E.; Florczyk, A.P.; Comis, R.L.; Crooke, S.T. 1981: Pharmacokinetics of carminomycin in dogs and humans. Preliminary report. Cancer ChemoTherapy and Pharmacology 6(2): 189-193

Weenen, H.; Pinedo, H.M.; de Planque, M.M.; Ten Bokkel Huinink, W.W.; McVie, J.G.; Lankelma, J. 1984: Pharmacokinetics of carminomycin in man: biweekly schedule vs single dose every three weeks. European Journal of Cancer and Clinical Oncology 20(7): 915-918

Ognianova, V.; Drensk, A.; Mikhaĭlova, D.; Nachev, I. 1981: Pharmacokinetics of carsyl (silymarin) in experimental animals. Eksperimentalna Meditsina i Morfologiia 20(4): 214-220

Clevidence, B.A.; Failla, M.L.; Vercellotti, J.R.; Pescador, R. 1983: Pharmacokinetics of catalytically tritiated glycosaminoglycans in the rat. Arzneimittel-Forschung 33(2): 228-230

Lildholdt, T.; Cantekin, E.I.; Marshak, G.; Bluestone, C.D.; Rohn, D.D.; Schuit, K.E. 1981: Pharmacokinetics of cefaclor in chronic middle ear effusions. Annals of Otology Rhinology and Laryngology. Suppl 90(3 Part 3): 44-47

Spyker, D.A.; Gober, L.L.; Scheld, W.M.; Sande, M.A.; Bolton, W.K. 1982: Pharmacokinetics of cefaclor in renal failure: effects of multiple doses and hemodialysis. Antimicrobial Agents and ChemoTherapy 21(2): 278-281

La Rosa, F.; Ripa, S.; Prenna, M.; Ghezzi, A.; Pfeffer, M. 1982: Pharmacokinetics of cefadroxil after oral administration in humans. Antimicrobial Agents and ChemoTherapy 21(2): 320-322

Hampel, B.; Lode, H.; Wagner, J.; Koeppe, P. 1982: Pharmacokinetics of cefadroxil and cefaclor during an eight-day dosage period. Antimicrobial Agents and ChemoTherapy 22(6): 1061-1063

Leroy, A.; Humbert, G.; Godin, M.; Fillastre, J.P. 1982: Pharmacokinetics of cefadroxil in patients with impaired renal function. Journal of Antimicrobial ChemoTherapy 10(Suppl): 39-46

Nakanomyo, H.; Imai, K.; Hiraoka, M.; Hasegawa, Y. 1980: Pharmacokinetics of cefadroxil in rats: comparison of fasting and non-fasting. Japanese Journal of Antibiotics 33(8): 778-781

Lunke, R.J.; Fitzgerald, R.H.; Washington, J.A. 1981: Pharmacokinetics of cefamandole in osseous tissue. Antimicrobial Agents and ChemoTherapy 19(5): 851-858

Klimova, V.S.; Bobrov, V.I.; Nazarova, O.I.; Skala, L.Z.; Iakovlev, V.P. 1982: Pharmacokinetics of cefamandole in rabbits. Antibiotiki 27(12): 34-38

Campillo, J.A.; Dominguez-Gil, A.A.; Cepeda, M.; Dominguez-Gil, A. 1980: Pharmacokinetics of cefamandole in rabbits with experimentally induced renal impairment. Journal of Antibiotics 33(3): 322-327

Bergan, T.; Orjavik, O.; Brodwall, E.K. 1981: Pharmacokinetics of cefapirin in patients with normal and impaired renal functions. Arzneimittel-Forschung 31(10): 1773-1776

Kirby, W.M.; Regamey, C. 1973: Pharmacokinetics of cefazolin compared with four other cephalosporins. Journal of Infectious Diseases 128(Suppl): s341-6

Welling, P.G.; Craig, W.A.; Gordon, A.L.; Kunin, C.M. 1974: Pharmacokinetics of cefazolin in normal and uremic subjects. Clinical Pharmacology and Therapeutics 15(4): 344-353

Leroy, A.; Canonne, M.A.; Fillastre, J.P.; Humbert, G. 1974: Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients. Current Therapeutic Research 16(9): 878-889

Ohkawa, M.; Orito, M.; Sugata, T.; Shimamura, M.; Sawaki, M.; Nakashita, E.; Kuroda, K.; Sasahara, K. 1980: Pharmacokinetics of cefmetazole in normal subjects and in patients with impaired renal function. Antimicrobial Agents and ChemoTherapy 18(3): 386-389

Barriere, S.L.; Hatheway, G.J.; Gambertoglio, J.G.; Lin, E.T.; Conte, J.E. 1982: Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin. Antimicrobial Agents and ChemoTherapy 21(6): 935-938

Rosenfeld, W.N.; Evans, H.E.; Batheja, R.; Jhaveri, R.C.; Vohra, K.; Khan, A.J. 1983: Pharmacokinetics of cefoperazone in full-term and premature neonates. Antimicrobial Agents and ChemoTherapy 23(6): 866-869

Bolton, W.K.; Scheld, W.M.; Spyker, D.A.; Sande, M.A. 1981: Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency. Antimicrobial Agents and ChemoTherapy 19(5): 821-825

Hodler, J.E.; Galeazzi, R.L.; Frey, B.; Rudhardt, M.; Seiler, A.J. 1984: Pharmacokinetics of cefoperazone in patients undergoing chronic ambulatory peritoneal dialysis: clinical and pathophysiological implications. European Journal of Clinical Pharmacology 26(5): 609-612

Maksymiuk, A.W.; LeBlanc, B.M.; Brown, N.S.; Ho, D.H.; Bodey, G.P. 1981: Pharmacokinetics of cefoperazone in patients with neoplastic disease. Antimicrobial Agents and ChemoTherapy 19(6): 1037-1041

Greenfield, R.A.; Gerber, A.U.; Craig, W.A. 1983: Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function. Reviews of Infectious Diseases 5(Suppl 1): S127-S136

Craig, W.A.; Gerber, A.U. 1981: Pharmacokinetics of cefoperazone: a review. Drugs 22(Suppl 1): 35-45

Ripa, S.; La Rosa, F.; Ghezzi, A.; Prenna, M.; Pfeffer, M. 1982: Pharmacokinetics of ceforanide. Antimicrobial Agents and ChemoTherapy 21(2): 323-326

Hess, J.R.; Berman, S.J.; Boughton, W.H.; Sugihara, J.G.; Musgrave, J.E.; Wong, E.G.; Siemsen, A.M. 1980: Pharmacokinetics of ceforanide in patients with end stage renal disease on hemodialysis. Antimicrobial Agents and ChemoTherapy 17(2): 251-253

Naber, K.; Adam, D. 1980: Pharmacokinetics of cefotaxim in geriatric patients. Mmw Munchener Medizinische Wochenschrift 122(46): 1651-1654

Matousovic, K.; Morávek, J.; Vítko, S.; Prát, V.; Horcicková, M.; Novák, Z.; Kuklík, R.; Krebs, V.; Janků, J. 1984: Pharmacokinetics of cefotaxime after I.v. and I.p. administration in patients treated with continual ambulatory peritoneal dialysis (CAPD). Casopis Lekaru Ceskych 123(22): 678-680

Höffken, G.; Lode, H.; Koeppe, P.; Ruhnke, M.; Borner, K. 1984: Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in cirrhosis of the liver. ChemoTherapy 30(1): 7-17

Crooks, J.; White, L.O.; Burville, L.J.; Speidel, B.D.; Reeves, D.S. 1984: Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in neonates. Journal of Antimicrobial ChemoTherapy 14 Suppl B: 97-101

Fillastre, J.P.; Ings, R.M.; Leroy, A.; Godin, M.; Humbert, G. 1982: Pharmacokinetics of cefotaxime and metabolites in uremic patients. Nephrologie 3(1): 12-18

Baird-Lambert, J.; Doyle, P.E.; Thomas, D.; Cvejic, M.; Buchanan, N. 1984: Pharmacokinetics of cefotaxime in neonates. Journal of Antimicrobial ChemoTherapy 13(5): 471-477

von Hattingberg, H.M.; Marget, W.; Belohradsky, B.H.; Roos, R. 1980: Pharmacokinetics of cefotaxime in neonates and children: clinical aspects. Journal of Antimicrobial ChemoTherapy 6(Suppl): 113-118

McCracken, G.H.; Threlkeld, N.E.; Thomas, M.L. 1982: Pharmacokinetics of cefotaxime in newborn infants. Antimicrobial Agents and ChemoTherapy 21(4): 683-684

Esmieu, F.; Guibert, J.; Rosenkilde, H.C.; Ho, I.; Le Go, A. 1980: Pharmacokinetics of cefotaxime in normal human volunteers. Journal of Antimicrobial ChemoTherapy 6(Suppl): 83-92

Hasegawa, H.; Imada, A.; Horiuchi, A.; Nishii, Y.; Fukushima, M.; Kurokawa, E. 1984: Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis. Journal of Antimicrobial ChemoTherapy 14 Suppl B: 135-142

Fillastre, J.P.; Ings, R.M.; Leroy, A.; Humbert, G.; Godin, M. 1981: Pharmacokinetics of cefotaxime in patients with chronic renal impairment. La Nouvelle Presse Medicale 10(8): 574-579

Guerrini, V.H.; Filippich, L.; English, P.B.; Bourne, D.W. 1983: Pharmacokinetics of cefotaxime in sheep. American Journal of Veterinary Research 44(8): 1488-1491

Fillastre, J.P.; Leroy, A.; Humbert, G.; Godin, M. 1980: Pharmacokinetics of cefotaxime in subjects with normal and impaired renal function. Journal of Antimicrobial ChemoTherapy 6(Suppl): 103-111

Nakagawa, K.; Koyama, M.; Tachibana, A.; Komiya, M.; Kikuchi, Y.; Yano, K. 1982: Pharmacokinetics of cefotetan (YM09330) in humans. Antimicrobial Agents and ChemoTherapy 22(6): 935-941

Tachibana, A.; Ikeda, C.; Yano, K. 1982: Pharmacokinetics of cefotetan and an aminoglycoside preparation in combined administration. 1. Individual quantification of cefotetan and sisomicin by bioassay and their absorption, distribution, and excretion in rats when given together. Japanese Journal of Antibiotics 35(6): 1411-1426

Ohkawa, M.; Hirano, S.; Tokunaga, S.; Motoi, I.; Shoda, R.; Ikeda, A.; Sugata, T.; Sawaki, M.; Shimamura, M.; Okasho, A.; Kuroda, K. 1983: Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function. Antimicrobial Agents and ChemoTherapy 23(1): 31-35

Daschner, F.D.; Hemmer, K.A.; Offermann, P.; Slanicka, J. 1982: Pharmacokinetics of cefotiam in normal humans. Antimicrobial Agents and ChemoTherapy 22(6): 958-960

Otero, M.J.; Garcia, M.J.; Barrueco, M.; Dominguez-Gil, A.; Gomez, F.; Portugal Alvarez, J. 1984: Pharmacokinetics of cefoxitin administered by I.v. infusion to patients with a pleural effusion. European Journal of Clinical Pharmacology 26(3): 389-392

Garcia, M.J.; Dominguez-Gil, A.A.; Cepeda, M.; Dominguez-Gil, A. 1981: Pharmacokinetics of cefoxitin administered intramuscularly to rabbits with experimentally-induced renal impairment. Biopharmaceutics and Drug Disposition 2(3): 205-213

Garcia, M.J.; Dominguez-Gil, A.; Tabernero, J.M.; Diaz Molina, M. 1983: Pharmacokinetics of cefoxitin during haemofiltration. European Journal of Clinical Pharmacology 25(3): 395-398

Flaherty, J.F.; Boswell, G.W.; Winkel, C.A.; Elliott, J.P. 1983: Pharmacokinetics of cefoxitin in patients at term gestation: lavage versus intravenous administration. American Journal of Obstetrics and Gynecology 146(7): 760-766

Garcia, M.J.; Otero, M.J.; Barrueco, M.; Dominguez-Gil, A. 1984: Pharmacokinetics of cefoxitin in patients with pleural effusion on a multiple dosage regimen. International Journal of Clinical Pharmacology Therapy and Toxicology 22(6): 300-303

Lakings, D.B.; Friis, J.M.; Brown, R.J.; Allen, H.R. 1984: Pharmacokinetics of cefpimizole in normal humans after single- and multiple-dose intravenous infusions. Antimicrobial Agents and ChemoTherapy 26(6): 802-806

Nakagawa, K.; Koyama, M.; Matsui, H.; Ikeda, C.; Yano, K.; Nakatsuru, N.; Yoshinaga, K.; Noguchi, T. 1984: Pharmacokinetics of cefpiramide (SM-1652) in humans. Antimicrobial Agents and ChemoTherapy 25(2): 221-225

Gerardin, A.; Lecaillon, J.B.; Schoeller, J.P.; Humbert, G.; Guibert, J. 1982: Pharmacokinetics of cefroxadin (CGP 9000) in man. Journal of Pharmacokinetics and Biopharmaceutics 10(1): 15-26

Ohkawa, M.; Takamae, K.; Shimamura, M.; Kuroda, K.; Awazu, S. 1981: Pharmacokinetics of cefroxadine in healthy volunteers and patients with impaired renal function. ChemoTherapy 27(3): 149-154

Sommers, D.K.; Walters, L.; Van Wyk, M.; Harding, S.M.; Paton, A.M.; Ayrton, J. 1983: Pharmacokinetics of ceftazidime in male and female volunteers. Antimicrobial Agents and ChemoTherapy 23(6): 892-896

Höffler, D.; Koeppe, P.; Williams, K.J. 1984: Pharmacokinetics of ceftazidime in normal and impaired renal function. Arzneimittel-Forschung 34(1): 72-76

Leroy, A.; Leguy, F.; Borsa, F.; Spencer, G.R.; Fillastre, J.P.; Humbert, G. 1984: Pharmacokinetics of ceftazidime in normal and uremic subjects. Antimicrobial Agents and ChemoTherapy 25(5): 638-642

Tourkantonis, A.; Nicolaidis, P. 1983: Pharmacokinetics of ceftazidime in patients undergoing peritoneal dialysis. Journal of Antimicrobial ChemoTherapy 12 Suppl A: 263-267

Welage, L.S.; Schultz, R.W.; Schentag, J.J. 1984: Pharmacokinetics of ceftazidime in patients with renal insufficiency. Antimicrobial Agents and ChemoTherapy 25(2): 201-204

Fillastre, J.P.; Humbert, G.; Olier, B.; Leguy, F.; Borsa, F.; Spenser, G.R. 1983: Pharmacokinetics of ceftazidime in renal failure. Journal of Antimicrobial ChemoTherapy 11(5): 487-488

Ohkawa, M.; Kuroda, K. 1980: Pharmacokinetics of ceftezole in patients with normal and impaired renal function. ChemoTherapy 26(4): 242-247

Hitzenberger, G. 1981: Pharmacokinetics of ceftizoxim. Wiener Medizinische Wochenschrift 131(15-16): 391-394

Murakawa, T.; Sakamoto, H.; Fukada, S.; Nakamoto, S.; Hirose, T.; Itoh, N.; Nishida, M. 1980: Pharmacokinetics of ceftizoxime in animals after parenteral dosing. Antimicrobial Agents and ChemoTherapy 17(2): 157-164

Burgess, E.D.; Blair, A.D. 1983: Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrobial Agents and ChemoTherapy 24(2): 237-239

Shah, P.M.; Knobloch, M.; Haag, R.; Kühnle, H.F. 1982: Pharmacokinetics of ceftizoxime in patients undergoing hemodialysis. Methods and Findings in Experimental and Clinical Pharmacology 4(3): 185-188

Kowalsky, S.F.; Echols, R.M.; Venezia, A.R.; Andrews, E.A. 1983: Pharmacokinetics of ceftizoxime in subjects with various degrees of renal function. Antimicrobial Agents and ChemoTherapy 24(2): 151-155

Adam, D.; Timmler, R. 1982: Pharmacokinetics of ceftizoxime with and without probenecid. Arzneimittel-Forschung 32(4): 416-419

McNamara, P.J.; Stoeckel, K.; Ziegler, W.H. 1982: Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose. European Journal of Clinical Pharmacology 22(1): 71-75

Prado, V.; Arancibia, A.; Aguirre, X. 1984: Pharmacokinetics of ceftriaxone in blood and ventricular cerebrospinal fluid in children with ventriculitis. Boletin Medico del Hospital Infantil de Mexico 41(6): 313-317

Patel, I.H.; Chen, S.; Parsonnet, M.; Hackman, M.R.; Brooks, M.A.; Konikoff, J.; Kaplan, S.A. 1981: Pharmacokinetics of ceftriaxone in humans. Antimicrobial Agents and ChemoTherapy 20(5): 634-641

Cohen, D.; Appel, G.B.; Scully, B.; Neu, H.C. 1983: Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis. Antimicrobial Agents and ChemoTherapy 24(4): 529-532

Steele, R.W.; Eyre, L.B.; Bradsher, R.W.; Weinfeld, R.E.; Patel, I.H.; Spicehandler, J. 1983: Pharmacokinetics of ceftriaxone in pediatric patients with meningitis. Antimicrobial Agents and ChemoTherapy 23(2): 191-194

Miyakawa, I.; Taniyama, K.; Nagai, K.; Yasuda, H.; Mori, N. 1984: Pharmacokinetics of ceftriaxone in the peripheral venous serum, uterine arterial serum and intrapelvic genital organs. Japanese Journal of Antibiotics 37(12): 2420-2426

Frederiksen, M.C.; Bowsher, D. 1983: Pharmacokinetics of cefuroxime. American Journal of Obstetrics and Gynecology 145(3): 381-382

Benoni, G.; Franco, L.; Conforti, A.; Totorizzo, A.; Velo, G.P. 1981: Pharmacokinetics of cefuroxime and cefoxitin in experimentally induced pleurisy in the rat. Giornale Italiano di Chemioterapia 28(1-2): 33-39

Del Rio, M.d.l.A.; Chrane, D.F.; Shelton, S.; McCracken, G.H.; Nelson, J.D. 1982: Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis. Antimicrobial Agents and ChemoTherapy 22(6): 990-994

Bundtzen, R.W.; Toothaker, R.D.; Nielson, O.S.; Madsen, P.O.; Welling, P.G.; Craig, W.A. 1981: Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays. Antimicrobial Agents and ChemoTherapy 19(3): 443-449

Philipson, A.; Stiernstedt, G. 1982: Pharmacokinetics of cefuroxime in pregnancy. American Journal of Obstetrics and Gynecology 142(7): 823-828

Regamey, C.; Humair, L. 1971: Pharmacokinetics of cephalexin in renal insufficiency. Postgraduate Medical Journal 47: Suppl: 69-78

Imoto, T. 1981: Pharmacokinetics of cephaloridine. Japanese Journal of Antibiotics 34(2): 180-187

Dvorácek, K.; Modr, Z.; Grafnetterová, J.; Bláha, V.; Necásková, A. 1969: Pharmacokinetics of cephaloridine in the human organism during its intravenous administration. Casopis Lekaru Ceskych 108(9): 258-263

Höffler, D.; Koeppe, P.; Fuchs, E.; Fiegel, P. 1971: Pharmacokinetics of cephalothin. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 77: 1019-1022

Regamey, C.; Kirby, W.M. 1973: Pharmacokinetics of cephanone in healthy adult volunteers. Antimicrobial Agents and ChemoTherapy 4(6): 589-592

Imoto, T. 1983: Pharmacokinetics of cephapirin sodium during intravenous infusion. Japanese Journal of Antibiotics 36(8): 2120-2128

Dvorácek, K.; Modr, Z.; Janků, I.; Krebs, V. 1981: Pharmacokinetics of cephazolin. Casopis Lekaru Ceskych 120(34): 1021-1025

Modr, Z.; Dvorácek, K.; Janků, I.; Krebs, V. 1982: Pharmacokinetics of cephradine. Ceskoslovenska Farmacie 31(5): 153-158

Roberts, D.H.; Kendall, M.J.; Jack, D.B.; Welling, P.G. 1981: Pharmacokinetics of cephradine given intravenously with and without probenecid. British Journal of Clinical Pharmacology 11(6): 561-564

Tuomisto, J. 1970: Pharmacokinetics of chemotherapeutic agents. Duodecim; Laaketieteellinen Aikakauskirja 86(4): 179-191

Bernareggi, A. 1995: Pharmacokinetics of chiral drugs. Bollettino Chimico Farmaceutico 134(2): 63-68

Grid'ko, A.N.; Borzunov, E.E.; Komissarenko, I.V.; Perepelitsa, N.P. 1981: Pharmacokinetics of chlodithane tablets in the treatment of Cushing's syndrome. Problemy Endokrinologii 27(2): 32-35

Ehrsson, H.; Wallin, I.; Nilsson, S.O.; Johansson, B. 1983: Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031). European Journal of Clinical Pharmacology 24(2): 251-253

Kauffman, R.E.; Miceli, J.N.; Strebel, L.; Buckley, J.A.; Done, A.K.; Dajani, A.S. 1981: Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children. Journal of Pediatrics 98(2): 315-320

Anderson, K.L.; Neff-Davis, C.A.; Davis, L.E.; Koritz, G.D.; Nelson, D.R. 1983: Pharmacokinetics of chloramphenicol in non-lactating cattle. Journal of Veterinary Pharmacology and Therapeutics 6(4): 305-313

Brumbaugh, G.W.; Martens, R.J.; Knight, H.D.; Martin, M.T. 1983: Pharmacokinetics of chloramphenicol in the neonatal horse. Journal of Veterinary Pharmacology and Therapeutics 6(3): 219-227

Gupta, R.C.; Paul, B.S.; Varma, K.J. 1980: Pharmacokinetics of chloramphenicol in the white leghorn Gallus domesticus. Indian Journal of Experimental Biology 18(6): 612-614

Bertler, A.; Lindgren, S.; Magnusson, J.O.; Malmgren, H. 1983: Pharmacokinetics of chlorazepate after intravenous and intramuscular administration. Psychopharmacology 80(3): 236-239

Friedman, E.; Cooper, T.B. 1983: Pharmacokinetics of chlorimipramine and its demethylated metabolite in blood and brain regions of rats treated acutely and chronically with chlorimipramine. Journal of Pharmacology and Experimental Therapeutics 225(2): 387-390

Aderounmu, A.F.; Fleckenstein, L. 1983: Pharmacokinetics of chloroquine diphosphate in the dog. Journal of Pharmacology and Experimental Therapeutics 226(3): 633-639

Huang, S.M.; Athanikar, N.K.; Sridhar, K.; Huang, Y.C.; Chiou, W.L. 1982: Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults. European Journal of Clinical Pharmacology 22(4): 359-365

Kaul, P.N.; Conway, M.W.; Clark, M.L. 1974: Pharmacokinetics of chlorpromazine metabolites--a colossal problem. Advances in Biochemical Psychopharmacology 9(0): 391-398

Pollet, R.A.; Glatz, C.E.; Dyer, D.C.; Barnes, H.J. 1983: Pharmacokinetics of chlortetracycline potentiation with citric acid in the chicken. American Journal of Veterinary Research 44(9): 1718-1721

Colussi, D.; Schoeller, J.P.; Richard, A.; Sioufi, A. 1983: Pharmacokinetics of chlorthalidone in the elderly after single and multiple doses. British Journal of Clinical Pharmacology 16(6): 755-756

Mulley, B.A.; Parr, G.D.; Rye, R.M. 1980: Pharmacokinetics of chlorthalidone. Dependence of biological half life on blood carbonic anhydrase levels. European Journal of Clinical Pharmacology 17(3): 203-207

Desiraju, R.K.; Renzi, N.L.; Nayak, R.K.; Ng, K.T. 1983: Pharmacokinetics of chlorzoxazone in humans. Journal of Pharmaceutical Sciences 72(9): 991-994

Rosati, G. 1970: Pharmacokinetics of cholecysto-cholangiographic contrast media. La Radiologia Medica 56(9): 808-820

Bodemar, G.; Norlander, B.; Walan, A. 1981: Pharmacokinetics of cimetidine after single doses and during continuous treatment. Clinical Pharmacokinetics 6(4): 306-315

Larsson, R.; Erlanson, P.; Bodemar, G.; Norlander, B.; Fransson, L.; Strouth, L. 1982: Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis. European Journal of Clinical Pharmacology 21(4): 325-330

Grahnén, A.; Jameson, S.; Lööf, L.; Tyllström, J.; Lindström, B. 1984: Pharmacokinetics of cimetidine in advanced cirrhosis. European Journal of Clinical Pharmacology 26(3): 347-355

Albin, H.; Couzigou, P.; Vinçon, G.; Péhourcq, F.; Fleury, B.; Béraud, C. 1983: Pharmacokinetics of cimetidine in ascitic cirrhotics. Gastroenterologie Clinique et Biologique 7(3): 251-255

Chin, T.W.; MacLeod, S.M.; Fenje, P.; Baltodano, A.; Edmonds, J.F.; Soldin, S.J. 1982: Pharmacokinetics of cimetidine in critically ill children. Pediatric Pharmacology 2(4): 285-292

Nation, R.L.; Ilett, K.F.; Tjokrosetio, R.; Oh, T.E.; Cameron, P.; Thompson, W. 1984: Pharmacokinetics of cimetidine in critically ill patients. European Journal of Clinical Pharmacology 26(3): 341-346

Bjaeldager, P.A.; Jensen, J.B.; Nielsen, L.P.; Larsen, N.E.; Hvidberg, E.F. 1983: Pharmacokinetics of cimetidine in patients undergoing hemodialysis. Nephron 34(3): 159-163

Rovati, V.; Foschi, D.; Benvenuti, C.; Alfieri, G. 1983: Pharmacokinetics of cimetidine in patients with unresponsive duodenal ulcer. International Journal of Clinical Pharmacology Research 3(2): 71-76

Harland, S.J.; Newell, D.R.; Siddik, Z.H.; Chadwick, R.; Calvert, A.H.; Harrap, K.R. 1984: Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function. Cancer Research 44(4): 1693-1697

Pendyala, L.; Greco, W.; Cowens, J.W.; Madajewicz, S.; Creaven, P.J. 1983: Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer. Cancer ChemoTherapy and Pharmacology 11(1): 23-28

Horiuchi, M.; Inuyama, Y.; Kohno, N.; Mashino, S.; Fujii, M. 1982: Pharmacokinetics of cis-dichlorodiammineplatinum (II). Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(4): 632-637

Sawada, M.; Okudaira, Y.; Matsui, Y.; Nishiura, H.; Yanagida, T. 1982: Pharmacokinetics of cis-platinum diammine dichloride. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(1): 55-65

Hayata, S.; Hitoshi, T.; Kiyokawa, K.; Esaki, S.; Mihashi, S.; Hirano, M. 1984: Pharmacokinetics of cisplatin and the effect of sodium thiosulfate. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(11): 2356-2361

Kelsen, D.P.; Hoffman, J.; Alcock, N.; Cheng, E.; Bailey, E.; Young, C.; Golbey, R.; Fortner, J. 1982: Pharmacokinetics of cisplatin regional hepatic infusions. American Journal of Clinical Oncology 5(2): 173-178

Bell, M.J.; Shackelford, P.; Smith, R.; Schroeder, K. 1984: Pharmacokinetics of clindamycin phosphate in the first year of life. Journal of Pediatrics 105(3): 482-486

Bourget, P.; Broise, I.; Quinquis-Desmaris, V.; Gabilan, J.C. 1995: Pharmacokinetics of clofibrate in jaundiced newborn infants at term. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 2(8): 722-728

De Cuyper, H.J.; van Praag, H.M.; Mulder-Hajonides, W.R.; Westenberg, H.G.; de Zeeuw, R.A. 1981: Pharmacokinetics of clomipramine in depressive patients. Psychiatry Research 4(2): 147-156

Al-Tahan, F.; Löscher, W.; Frey, H.H. 1984: Pharmacokinetics of clonazepam in the dog. Archives Internationales de Pharmacodynamie et de Therapie 268(2): 180-193

Lowenthal, D.T. 1980: Pharmacokinetics of clonidine. Journal of Cardiovascular Pharmacology 2 Suppl. 1: S29-S37

Arndts, D.; Doevendans, J.; Arendt, G.; Rippen, G. 1981: Pharmacokinetics of clonidine and chlorthalidone following subacute administration of a fixed combination compared with a sustained release formulation of clonidine alone. Arzneimittel-Forschung 31(11): 1954-1957

Ahmad, T.; Khursheed, S.M.; Aslam, M. 1983: Pharmacokinetics of cloxacillin in humans. Jpma. Journal of the Pakistan Medical Association 33(12): 299-303

Nauta, E.H.; Mattie, H.; Goslings, W.R. 1973: Pharmacokinetics of cloxacillin in patients on chronic intermittent haemodialysis and in healthy subjects. ChemoTherapy 19(5): 261-271

Naber, K.; Vergin, H.; Weigand, W. 1981: Pharmacokinetics of co-trimoxazole and co-tetroxazine in geriatric patients. Infection 9(5): 239-243

Gheorghe, N. 1972: Pharmacokinetics of colloidal gold (au 198) after intra-articular and intravenous administration in rabbits and rats. Revue Roumaine de Physiologie 9(2): 145-150

Heimann, G.; Schug, S.; Bergt, U. 1983: Pharmacokinetics of combined antibiotic therapy in the newborn infant. Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 131(2): 58-62

Bunke, C.M.; Aronoff, G.R.; Luft, F.C. 1983: Pharmacokinetics of common antibiotics used in continuous ambulatory peritoneal dialysis. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 3(2): 114-117

Miller, R.D. 1982: Pharmacokinetics of competitive muscle relaxants. British Journal of Anaesthesia 54(2): 161-167

Tse, F.L.; Jaffe, J.M.; Dain, J.G. 1984: Pharmacokinetics of compound 58-112, a potential skeletal muscle relaxant, in man. Journal of Clinical Pharmacology 24(1): 47-57

Weinstein, H.J.; Griffin, T.W.; Feeney, J.; Cohen, H.J.; Propper, R.D.; Sallan, S.E. 1982: Pharmacokinetics of continuous intravenous and subcutaneous infusions of cytosine arabinoside. Blood 59(6): 1351-1353

Schetz, M.; Ferdinande, P.; Van den Berghe, G.; Verwaest, C.; Lauwers, P. 1995: Pharmacokinetics of continuous renal replacement therapy. Intensive Care Medicine 21(7): 612-620

Lauritzen, T.; Pramming, S.; Deckert, T.; Binder, C. 1983: Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia 24(5): 326-329

Kimbel, K.H. 1971: Pharmacokinetics of contraceptive steroids. Journal of Reproduction and Fertility 27(2): 302-303

Gardeur, D.; Lautrou, J.; Millard, J.C.; Berger, N.; Metzger, J. 1980: Pharmacokinetics of contrast media: experimental results in dog and man with CT implications. Journal of Computer Assisted Tomography 4(2): 178-185

Ritschel, W.A.; Grummich, K.W. 1981: Pharmacokinetics of coumarin and 7-hydroxycoumarin upon I.v. and p.o. administration in the euthyroid and hypothyroid beagle dog. Arzneimittel-Forschung 31(4): 643-649

Ritschel, W.A.; Hardt, T.J. 1983: Pharmacokinetics of coumarin, 7-hydroxycoumarin and 7-hydroxycoumarin glucuronide in the blood and brain of gerbils following intraperitoneal administration of coumarin. Arzneimittel-Forschung 33(9): 1254-1258

Marzo, A.; Ghirardi, P.; Croce, G. 1972: Pharmacokinetics of creatinol-o-phosphate. La Clinica Terapeutica 62(5): 419-430

Voelcker, G.; Haeglsperger, R. 1982: Pharmacokinetics of cyclophosphamide and cyclophosphamide metabolites in the mouse and their influence on the therapeutic effect of "activated" cyclophosphamide (4-hydroxycyclophosphamide). Arzneimittel-Forschung 32(6): 639-647

Juma, F.D.; Koech, D.K.; Kasili, E.G.; Ogada, T. 1984: Pharmacokinetics of cyclophosphamide in Kenyan African children with lymphoma. British Journal of Clinical Pharmacology 18(1): 106-107

Juma, F.; Ogada, T. 1983: Pharmacokinetics of cyclophosphamide in Kenyan Africans. British Journal of Clinical Pharmacology 16(1): 61-63

Cohen, J.L.; Jao, J.Y.; Jusko, W.J. 1971: Pharmacokinetics of cyclophosphamide in man. British Journal of Pharmacology 43(3): 677-680

Zítková, L.; Tousek, J. 1974: Pharmacokinetics of cycloserine and terizidone. a comparative study. ChemoTherapy 20(1): 18-28

Claris, O.; Picaud, J.C.; Brazier, J.L.; Salle, B.L. 1993: Pharmacokinetics of cyclosporin a in 16 newborn infants of renal or cardiac transplant mothers. Developmental Pharmacology and Therapeutics 20(3-4): 180-185

Silva Junior, H.T.; Pereira, A.B.; Ajzen, H.; Bueno, V.; Pestana, J.O. 1994: Pharmacokinetics of cyclosporine and its metabolites in patients undergoing kidney transplantation. Revista da Associacao Medica Brasileira 40(3): 159-171

Vaden, S.L.; Cullen, J.M.; Riviere, J.E. 1995: Pharmacokinetics of cyclosporine in woodchucks and Pekin ducks. Journal of Veterinary Pharmacology and Therapeutics 18(1): 30-33

Kolb, K.H.; Roepke, H. 1968: Pharmacokinetics of cyproterone acetate. a comparative study in humans and baboons. Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 1(3): 184-190

Matteo, R.S.; Nishitateno, K.; Pua, E.K.; Spector, S. 1980: Pharmacokinetics of d-tubocurarine in man: effect of an osmotic diuretic on urinary excretion. Anesthesiology 52(4): 335-338

Martyn, J.A.; Matteo, R.S.; Greenblatt, D.J.; Lebowitz, P.W.; Savarese, J.J. 1982: Pharmacokinetics of d-tubocurarine in patients with thermal injury. Anesthesia and Analgesia 61(3): 241-246

Breithaupt, H.; Dammann, A.; Aigner, K. 1982: Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules. Cancer ChemoTherapy and Pharmacology 9(2): 103-109

Nilsson, S.O.; Andersson, B.; Eksborg, S.; Beran, M.; Ehrsson, H. 1981: Pharmacokinetics of daunorubicin after administration as free drug or as DNA complex in leukemic patients. Cancer ChemoTherapy and Pharmacology 5(4): 261-266

Marzo, A.; Ghirardi, P.; Barlattani, M.; Lentini, S. 1982: Pharmacokinetics of deslanoside C-3H administered orally to healthy volunteers. Il Farmaco; Edizione Pratica 37(1): 28-37

Toutain, P.L.; Alvinerie, M.; Ruckebusch, Y. 1983: Pharmacokinetics of dexamethasone and its effect on adrenal gland function in the dog. American Journal of Veterinary Research 44(2): 212-217

Charles, B.; Schild, P.; Steer, P.; Cartwright, D.; Donovan, T. 1993: Pharmacokinetics of dexamethasone following single-dose intravenous administration to extremely low birth weight infants. Developmental Pharmacology and Therapeutics 20(3-4): 205-210

Richter, O.; Ern, B.; Reinhardt, D.; Becker, B. 1983: Pharmacokinetics of dexamethasone in children. Pediatric Pharmacology 3(3-4): 329-337

George, C.F.; Fenyvesi, T.; Conolly, M.E.; Dollery, C.T. 1972: Pharmacokinetics of dextro-, laevo- and racemic propranolol in man. European Journal of Clinical Pharmacology 4(2): 74-76

Crome, P.; Gain, R.; Ghurye, R.; Flanagan, R.J. 1984: Pharmacokinetics of dextropropoxyphene and nordextropropoxyphene in elderly hospital patients after single and multiple doses of distalgesic. Preliminary analysis of results. Human Toxicology 3 Suppl: 41s-48s

Simiand, J.; Eymard, P.; Ferrandes, B.; Polverelli, M. 1973: Pharmacokinetics of di-n-propylacetamide in rats after oral administration. Annales Pharmaceutiques Francaises 31(3): 205-216

Raaflaub, J.; Frey, P. 1972: Pharmacokinetics of diallyl-nor-toxiferine in man. Arzneimittel-Forschung 22(1): 73-78

Siemensen, H.C.; Augustin, H.J. 1973: Pharmacokinetics of diatrizoate during hemodialysis. International Journal of Clinical Pharmacology Therapy and Toxicology 8(1): 22-29

Viukari, M.; Salo, H.; Lamminsivu, U.; Auvinen, R.; Gordin, A. 1981: Pharmacokinetics of diazepam administered rectally in geriatric patients: comparison of suppositories with rectal tubes in a cross-over study. Acta Pharmacologica et Toxicologica 49(1): 59-64

Cotler, S.; Gustafson, J.H.; Colburn, W.A. 1984: Pharmacokinetics of diazepam and nordiazepam in the cat. Journal of Pharmaceutical Sciences 73(3): 348-351

Wills, R.J. 1984: Pharmacokinetics of diazepam from a controlled release capsule in healthy elderly volunteers. Biopharmaceutics and Drug Disposition 5(3): 241-249

van der Klejin, E.; van Rossum, J.M.; Muskens, E.T.; Rijntjes, N.V. 1971: Pharmacokinetics of diazepam in dogs, mice and humans. Acta Pharmacologica et Toxicologica 29(Suppl): 109-127

Dhillon, S.; Richens, A. 1981: Pharmacokinetics of diazepam in epileptic patients and normal volunteers following intravenous administration. British Journal of Clinical Pharmacology 12(6): 841-844

Klotz, U.; Avant, G.R.; Hoyumpa, A.; Schenker, S.; Wilkinson, G.R. 1974: Pharmacokinetics of diazepam in man. Naunyn-Schmiedeberg's Archives of Pharmacology 282(Suppl): R48

Löscher, W.; Frey, H.H. 1981: Pharmacokinetics of diazepam in the dog. Archives Internationales de Pharmacodynamie et de Therapie 254(2): 180-195

Viotte, G.; Leroy, A.; Godin, M.; Fillastre, J.P. 1982: Pharmacokinetics of dibekacin in patients with chronic renal impairment. La Nouvelle Presse Medicale 11(46): 3414-3418

Komiya, I.; Murata, S.; Umemura, K.; Tomono, N.; Kikai, S.; Fujita, M. 1981: Pharmacokinetics of dibekacin in rabbits and dogs. Journal of Pharmacobio-Dynamics 4(5): 362-373

Thauvin, C.; Borsa, F.; Leroy, A.; Humbert, G. 1982: Pharmacokinetics of dibekacin in subjects with normal renal function. La Nouvelle Presse Medicale 11(46): 3410-3413

Gauch, R.; Modestin, J. 1973: Pharmacokinetics of dibenzepin. Arzneimittel-Forschung 23(5): 687-689

Karim, A. 1993: Pharmacokinetics of diclofenac and misoprostol when administered alone or as a combination product. Drugs 45(Suppl 1): 7

Said, S.A.; Sharaf, A.A. 1981: Pharmacokinetics of diclofenac sodium using a developed HPLC method. Arzneimittel-Forschung 31(12): 2089-2092

Singh, G.J.; Thornhill, R.A. 1980: Pharmacokinetics of dieldrin with special reference to its metabolism in the epicuticular wax layer in Calliphora erythrocephala. General Pharmacology 11(3): 283-292

Fotherby, K.; Hamawi, A.; Howard, G.; Bye, P.G.; Elder, M. 1984: Pharmacokinetics of different doses of norethisterone oenanthate. Contraception 29(4): 325-333

Beermann, B. 1974: Pharmacokinetics of digitalis glycosides. Drugs 7(6): 482-485

Finch, M.B.; Johnston, G.D.; Kelly, J.G.; McDevitt, D.G. 1984: Pharmacokinetics of digoxin alone and in the presence of indomethacin therapy. British Journal of Clinical Pharmacology 17(3): 353-355

Rietbrock, N.; Abshagen, U.; von Bergmann, K.; Kewitz, H. 1972: Pharmacokinetics of digoxin and its 4'''-acetyl- and methylderivates in the rat. Naunyn-Schmiedeberg's Archives of Pharmacology 274(2): 171-181

Gilfrich, H.J.; Bodem, G.; Chidsey, C.A. 1973: Pharmacokinetics of digoxin following acute and chronic administration. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1039-1042

De Paepe, M.; Belpaire, F.; Bogaerts, Y. 1982: Pharmacokinetics of digoxin in C.A.P.D. Clinical and Experimental Dialysis and Apheresis 6(1): 65-73

Koritz, G.D.; Anderson, K.L.; Neff-Davis, C.A.; Wilcke, J.R.; Davis, L.E. 1983: Pharmacokinetics of digoxin in cattle. Journal of Veterinary Pharmacology and Therapeutics 6(2): 141-147

Collins-Nakai, R.L.; Schiff, D.; Ng, P.K. 1982: Pharmacokinetics of digoxin in low-birth-weight infants. Developmental Pharmacology and Therapeutics 5(1-2): 86-97

Schenck-Gustafsson, K.; Dahlqvist, R. 1981: Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction. British Journal of Clinical Pharmacology 11(2): 181-186

Luxford, A.M.; Kellaway, G.S. 1983: Pharmacokinetics of digoxin in pregnancy. European Journal of Clinical Pharmacology 25(1): 117-121

Van der Aa, G.C. 1984: Pharmacokinetics of digoxin in the aged. Tijdschrift Voor Gerontologie en Geriatrie 15(2): 67-71

Park, E.; Einzig, S.; Staley, N.A.; Noren, G.R. 1981: Pharmacokinetics of digoxin in the turkey and comparison with other species. Journal of Pharmacokinetics and Biopharmaceutics 9(3): 357-366

Wildmeister, W.; Strobach, H.; Greeff, K.; Horster, F.A. 1973: Pharmacokinetics of digoxin, acetyldigoxin and methyldigoxin in healthy and ill persons. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1037-1039

Kramer, W.G.; Lewis, R.P.; Cobb, T.C.; Forester, W.F.; Visconti, J.A.; Wanke, L.A.; Boxenbaum, H.G.; Reuning, R.H. 1974: Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man. Journal of Pharmacokinetics and Biopharmaceutics 2(4): 299-312

Sanchez, N.; Sheiner, L.B.; Halkin, H.; Melmon, K.L. 1973: Pharmacokinetics of digoxin: interpreting bioavailability. British Medical Journal 4(5885): 132-134

Iakovlev, V.P. 1973: Pharmacokinetics of dihaloid substituted isoxazolyl penicillins. Antibiotiki 18(10): 915-918

Mrhar, A.; Kopitar, Z.; Kozjek, F.; Krusic, L.; Lenardic, A. 1983: Pharmacokinetics of dihydroergosine in rats after intravenous and oral administration. European Journal of Drug Metabolism and Pharmacokinetics 8(1): 17-20

Kanto, J.; Allonen, H.; Koski, K.; Koulu, M.; Lammintausta, R.; Mäntylä, R.; Kleimola, T.; Siirtola, T. 1981: Pharmacokinetics of dihydroergotamine in healthy volunteers and in neurological patients after a single intravenous injection. International Journal of Clinical Pharmacology Therapy and Toxicology 19(3): 127-130

Vladimirskiĭ, M.A.; Ladygina, G.A.; Stepanov, V.M. 1984: Pharmacokinetics of dihydrostreptomycin, after intravenous administration as a liposomal preparation, in the blood serum and tissues of intact mice and those with generalized tuberculosis. Antibiotiki 29(4): 282-285

Hermann, P.; Rodger, S.D.; Remones, G.; Thenot, J.P.; London, D.R.; Morselli, P.L. 1983: Pharmacokinetics of diltiazem after intravenous and oral administration. European Journal of Clinical Pharmacology 24(3): 349-352

Piepho, R.W.; Bloedow, D.C.; Lacz, J.P.; Runser, D.J.; Dimmit, D.C.; Browne, R.K. 1982: Pharmacokinetics of diltiazem in selected animal species and human beings. American Journal of Cardiology 49(3): 525-528

Pozet, N.; Brazier, J.L.; Aïssa, A.H.; Khenfer, D.; Faucon, G.; Apoil, E.; Traeger, J. 1983: Pharmacokinetics of diltiazem in severe renal failure. European Journal of Clinical Pharmacology 24(5): 635-638

Klinger, W. 1969: Pharmacokinetics of dimeylaminophenazone, 4-aminophenazone and phenazone in rats of various ages. Archives Internationales de Pharmacodynamie et de Therapie 180(2): 309-322

Bertler, A.; Lindgren, S.; Malmgren, H. 1980: Pharmacokinetics of dipotassium chlorazepate in patients after repeated 50 mg oral doses. Psychopharmacology 71(2): 165-167

Francois, B.; Mallein, R.; Rondelet, J.; Lussignol, M. 1983: Pharmacokinetics of disopyramide in patients with chronic renal failure. European Journal of Drug Metabolism and Pharmacokinetics 8(1): 85-92

Landmark, K.; Bredesen, J.E.; Thaulow, E.; Simonsen, S.; Amlie, J.P. 1981: Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure. European Journal of Clinical Pharmacology 19(3): 187-192

van der Kleijn, E. 1971: Pharmacokinetics of distribution and metabolism of ataractic drugs and an evaluation of the site of antianxiety activity. Annals of the New York Academy of Sciences 179: 115-125

Kindler, J.; Schulz, V. 1981: Pharmacokinetics of diuretics and antihypertensives in renal insufficiency. Der Internist 22(10): 607-615

Aranda, J.V.; Turmen, T.; Sasyniuk, B.I. 1980: Pharmacokinetics of diuretics and methylxanthines in the neonate. European Journal of Clinical Pharmacology 18(1): 55-63

Song, J.G.; Sun, R.Y. 1983: Pharmacokinetics of double-bottle intravenous infusion. Yao Xue Xue Bao 18(10): 732-740

Minchin, R.F.; Johnston, M.R.; Aiken, M.A.; Boyd, M.R. 1984: Pharmacokinetics of doxorubicin in isolated lung of dogs and humans perfused in vivo. Journal of Pharmacology and Experimental Therapeutics 229(1): 193-198

Modr, Z.; Dvorácek, K.; Schmidt, O. 1974: Pharmacokinetics of doxycycline. Casopis Lekaru Ceskych 113(35): 1063-1066

Modr, Z.; Dvorzhachek, K.; Shmidt, O.; Nechaskova, A. 1974: Pharmacokinetics of doxycycline in its repeated peroral administration. Antibiotiki 19(12): 1063-1067

Bononi, L.J.; Ceccarelli, G.; Ciaffi, G. 1972: Pharmacokinetics of doxycycline in the developmental age. Bollettino Chimico Farmaceutico 111(11): 700-708

Saux, M.C.; Mosser, J.; Pontagnier, H.; Leng, B. 1982: Pharmacokinetics of doxycycline polyphosphate after oral multiple dosing in humans. European Journal of Drug Metabolism and Pharmacokinetics 7(2): 123-130

Pedersen, P.V.; Miller, R. 1980: Pharmacokinetics of doxycycline reabsorption. Journal of Pharmaceutical Sciences 69(2): 204-207

Levy, G.; Gibaldi, M. 1972: Pharmacokinetics of drug action. Annual Review of Pharmacology 12: 85-98

Prandota, J. 1983: Pharmacokinetics of drug excretion in children. Polski Tygodnik Lekarski 38(51-52): 1601-1604

Skakun, N.P. 1982: Pharmacokinetics of drug preparations metabolized by N-acetyltransferase. Klinicheskaia Meditsina 60(1): 24-27

Ulrich, G. 1984: Pharmacokinetics of drugs. Soins; la Revue de Reference Infirmiere 439: 27-31

Holazo, A.A.; Colburn, W.A. 1982: Pharmacokinetics of drugs during various detoxification procedures for overdose and environmental exposure. Drug Metabolism Reviews 13(4): 715-743

Reinhardt, D.; Richter, O.; Brandenburg, G. 1983: Pharmacokinetics of drugs from the breast-feeding mother passing into the body of the infant, using theophylline as an example. Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 131(2): 66-70

Chen, M.L.; Lee, M.G.; Chiou, W.L. 1983: Pharmacokinetics of drugs in blood III: Metabolism of procainamide and storage effect of blood samples. Journal of Pharmaceutical Sciences 72(5): 572-574

Lee, M.G.; Chen, M.L.; Huang, S.M.; Chiou, W.L. 1981: Pharmacokinetics of drugs in blood. I. Unusual distribution of gentamicin. Biopharmaceutics and Drug Disposition 2(1): 89-97

Abernethy, D.R.; Greenblatt, D.J. 1982: Pharmacokinetics of drugs in obesity. Clinical Pharmacokinetics 7(2): 108-124

Kuprash, L.P.; Dzhemaĭlo, V.I. 1981: Pharmacokinetics of drugs in relation to age (review of the literature). Vrachebnoe Delo 1981(8): 15-20

Petrin, A. 1974: Pharmacokinetics of drugs in the elderly. International Journal of Clinical Pharmacology Therapy and Toxicology 9(2): 157-159

Lee, C.C.; Wang, L.H.; Majeske, B.L.; Marbury, T.C. 1981: Pharmacokinetics of dyphylline elimination by uremic patients. Journal of Pharmacology and Experimental Therapeutics 217(2): 340-344

Morris, R.B.; Cronnelly, R.; Miller, R.D.; Stanski, D.R.; Fahey, M.R. 1981: Pharmacokinetics of edrophonium and neostigmine when antagonizing d-tubocurarine neuromuscular blockade in man. Anesthesiology 54(5): 399-401

Morris, R.B.; Cronnelly, R.; Miller, R.D.; Stanski, D.R.; Fahey, M.R. 1981: Pharmacokinetics of edrophonium in anephric and renal transplant patients. British Journal of Anaesthesia 53(12): 1311-1314

Elliott, H.L.; Meredith, P.A.; Reid, J.L. 1984: Pharmacokinetics of endralazine. European Journal of Clinical Pharmacology 26(5): 661

Lunell, E.; Borgå, O.; Larsson, R. 1984: Pharmacokinetics of enprofylline in patients with impaired renal function after a single intravenous dose. European Journal of Clinical Pharmacology 26(1): 87-93

Albright, P.S.; Bruni, J.; Suria, D. 1984: Pharmacokinetics of enteric-coated valproic acid. Therapeutic Drug Monitoring 6(1): 21-23

Nordberg, G.; Hedner, T.; Mellstrand, T.; Borg, L. 1984: Pharmacokinetics of epidural morphine in man. European Journal of Clinical Pharmacology 26(2): 233-237

Fish, S.S.; Pancorbo, S.; Berkseth, R. 1981: Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis. Journal of Neurosurgery 54(6): 736-739

Bhavnani, B.R.; Woolever, C.A.; Benoit, H.; Wong, T. 1983: Pharmacokinetics of equilin and equilin sulfate in normal postmenopausal women and men. Journal of Clinical Endocrinology and Metabolism 56(5): 1048-1056

Schalhorn, A.; Sauer, H.; Wilmanns, W.; Stupp-Poutot, G. 1982: Pharmacokinetics of erythrocyte methotrexate after high-dose methotrexate. Cancer ChemoTherapy and Pharmacology 9(1): 65-69

Patamasucon, P.; Kaojarern, S.; Kusmiesz, H.; Nelson, J.D. 1981: Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age. Antimicrobial Agents and ChemoTherapy 19(5): 736-739

Prescott, J.F.; Hoover, D.J.; Dohoo, I.R. 1983: Pharmacokinetics of erythromycin in foals and in adult horses. Journal of Veterinary Pharmacology and Therapeutics 6(1): 67-73

Hall, K.W.; Nightingale, C.H.; Gibaldi, M.; Nelson, E.; Bates, T.R.; DiSanto, A.R. 1982: Pharmacokinetics of erythromycin in normal and alcoholic liver disease subjects. Journal of Clinical Pharmacology 22(7): 321-325

Johnson, A.L.; van Tienhoven, A. 1981: Pharmacokinetics of estradiol-17 beta in the laying hen. Poultry Science 60(12): 2720-2723

Gunnarsson, P.O.; Andersson, S.B.; Johansson, S.A.; Nilsson, T.; Plym-Forshell, G. 1984: Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients. European Journal of Clinical Pharmacology 26(1): 113-119

Fujimiya, T.; Fukui, Y.; Komura, S. 1995: Pharmacokinetics of ethanol drinking--absorption kinetics and first-pass effect. Nihon Hoigaku Zasshi 49(2): 92-103

Burov, I.V.; Vlasova, N.V.; Kampov-Polevoĭ, A.B.; Rodionov, A.P. 1983: Pharmacokinetics of ethanol in the blood of rats in various stages of chronic alcoholism. Voprosy Meditsinskoi Khimii 29(6): 24-26

Wilkinson, P.K. 1980: Pharmacokinetics of ethanol: a review. Alcoholism Clinical and Experimental Research 4(1): 6-21

Claussen, C.; Chemnitius, K.H.; Naumann, A.; Huebler, D. 1984: Pharmacokinetics of ethynyl estradiolsulfonate in minipigs. Hormone Research 19(1): 57-64

Fotherby, K. 1982: Pharmacokinetics of ethynyloestradiol in humans. Methods and Findings in Experimental and Clinical Pharmacology 4(2): 133-141

Fotherby, K.; Akpoviroro, J.; Abdel-Rahman, H.A.; Toppozada, H.K.; de Souza, J.C.; Coutinho, E.M.; Koetsawang, S.; Nukulkarn, P.; Sheth, U.K.; Mapa, M.K.; Gopalan, S.; Plunkett, E.R.; Brenner, P.F.; Hickey, M.V.; Grech, E.S.; Lichtenberg, R.; Gual, C.; Molina, R.; Gomez-Rogers, C.; Kwon, E.; Kim, S.W.; Chan, T.; Ratnam, S.S.; Landgren, B.M.; Shearman, R.P.; Goldzieher, J.W.; Dozier, T.S. 1981: Pharmacokinetics of ethynyloestradiol in women for different populations. Contraception 23(5): 487-496

Pedersen, H.; Morishima, H.O.; Finster, M.; Arthur, G.R.; Covino, B.G. 1982: Pharmacokinetics of etidocaine in fetal and neonatal lambs and adult sheep. Anesthesia and Analgesia 61(2): 104-108

Zuidema, J.; Verhoeven, J.; Merkus, F.W. 1981: Pharmacokinetics of etofylline after intravenous and oral administration to humans. International Journal of Clinical Pharmacology Therapy and Toxicology 19(7): 310-313

Hebron, B.S.; Edbrooke, D.L.; Newby, D.M.; Mather, S.J. 1983: Pharmacokinetics of etomidate associated with prolonged I.v. infusion. British Journal of Anaesthesia 55(4): 281-287

Schüttler, J.; Wilms, M.; Lauven, P.M.; Stoeckel, H.; Koenig, A. 1980: Pharmacokinetics of etomidate in man. Der Anaesthesist 29(12): 658-661

De Ruiter, G.; Popescu, D.T.; de Boer, A.G.; Smeekens, J.B.; Breimer, D.D. 1981: Pharmacokinetics of etomidate in surgical patients. Archives Internationales de Pharmacodynamie et de Therapie 249(2): 180-188

Sinkule, J.A.; Hutson, P.; Hayes, F.A.; Etcubanas, E.; Evans, W. 1984: Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors. Cancer Research 44(7): 3109-3113

Matucci, M.; Longo, G.; Morfini, M.; Vannini, S.; Messori, A.; Donati-Cori, G.; Tendi, E. 1983: Pharmacokinetics of factor VIII:C. Appropriateness of the one-compartment model for estimating clearance. Il Farmaco; Edizione Pratica 38(8): 306-311

Marriner, S.E.; Bogan, J.A. 1981: Pharmacokinetics of fenbendazole in sheep. American Journal of Veterinary Research 42(7): 1146-1148

Henson, R.; Lloyd-Jones, J.G.; Nichols, J.D.; Jordan, B.J. 1980: Pharmacokinetics of fenclofenac following single and multiple doses. European Journal of Drug Metabolism and Pharmacokinetics 5(4): 217-223

Mäkelä, A.L.; Scheinin, M.; Iisalo, E.; Salonen, J.S. 1983: Pharmacokinetics of fenclofenac in children with juvenile rheumatoid arthritis. European Journal of Clinical Pharmacology 25(3): 381-388

Platt, D.S. 1971: Pharmacokinetics of fenclozic acid in animals and man. Journal of Pharmaceutical Sciences 60(3): 366-371

Harvengt, C.; Desager, J.P. 1980: Pharmacokinetics of fenofibrate in man. La Nouvelle Presse Medicale 9(49): 3725-3727

Zanolo, G.; Giachetti, C.; Mondino, A.; Silvestri, S.; Bianchi, E.; Segre, G.; Gomarasca, P.; De Marchi, G. 1981: Pharmacokinetics of fentiazac in rats and monkeys. Arzneimittel-Forschung 31(7): 1098-1104

Levy, G. 1981: Pharmacokinetics of fetal and neonatal exposure to drugs. Obstetrics and Gynecology 58(5 Suppl): 9s

Dvorácek, K.; Modr, Z.; Necásková, A. 1974: Pharmacokinetics of flucloxacillin and nafcillin. Casopis Lekaru Ceskych 113(14): 427-431

Palestine, A.G.; Brubaker, R.F. 1981: Pharmacokinetics of fluorescein in the vitreous. Investigative Ophthalmology and Visual Science 21(4): 542-549

Pescador, R.; Madonna, M. 1982: Pharmacokinetics of fluorescein-labelled glycosaminoglycans and of their lipoprotein lipase-inducing activity in the rat. Arzneimittel-Forschung 32(8): 819-824

LeCompte, E.J.; Whitford, G.M. 1982: Pharmacokinetics of fluoride from APF gel and fluoride tablets in children. Journal of Dental Research 61(3): 469-472

Börner, W.; Eichner, R.; Henschler, D.; Moll, E.; Ruppert, G. 1980: Pharmacokinetics of fluorides in thyroid dysfunctions. the plasma fluoride concentration after oral administration of 40 mg of NaF in delayed and nondelayed form depending on the thyroid function. Fortschritte der Medizin 98(28): 1083-1086

Fujita, H. 1984: Pharmacokinetics of fluoropyrimidines. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(11): 2307-2315

Vranckx, C.H.; De Schepper, P.J.; Hansen, T. 1974: Pharmacokinetics of flupentixol decanoate. Acta Psychiatrica Belgica 74(5): 529-532

Blair, J.A.; Beavon, J.R.; Dransfield, E.; Leeming, R.J.; Ratanasthien, K.; Staff, F.J. 1974: Pharmacokinetics of folates in the rat and man. Clinical Science and Molecular Medicine 47(5): 21P

Federspil, P.; Tiesler, E.; Schätzle, W. 1982: Pharmacokinetics of fosfomycin and otitis media. Laryngologie Rhinologie Otologie 61(10): 591-594

Murakawa, T.; Sakamoto, H.; Fukada, S.; Konishi, T.; Nishida, M. 1982: Pharmacokinetics of fosmidomycin, a new phosphonic acid antibiotic. Antimicrobial Agents and ChemoTherapy 21(2): 224-230

Vermorken, J.B.; van der Vijgh, W.J.; Klein, I.; Hart, A.A.; Gall, H.E.; Pinedo, H.M. 1984: Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treatment Reports 68(3): 505-513

Emons, G.; Grühn-Schultek, K.M.; Isedor, S.; Ball, P.; Knuppen, R. 1982: Pharmacokinetics of free catecholestrogens and catecholestrogen benzoates. Steroids 39(3): 291-300

Vermorken, J.B.; van der Vijgh, W.J.; Klein, I.; Gall, H.E.; Pinedo, H.M. 1982: Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications. European Journal of Cancer and Clinical Oncology 18(11): 1069-1074

Rigobello, M.P.; Galzigna, L. 1982: Pharmacokinetics of fructose-1, 6-diphosphate in the rat. Il Farmaco; Edizione Scientifica 37(7): 459-462

Anttila, M.I.; Sotaniemi, E.A.; Kairaluoma, M.I.; Mokka, R.E.; Sundquist, H.T. 1983: Pharmacokinetics of ftorafur after intravenous and oral administration. Cancer ChemoTherapy and Pharmacology 10(3): 150-153

Huang, C.M.; Atkinson, A.J.; Levin, M.; Levin, N.W.; Quintanilla, A. 1974: Pharmacokinetics of furosemide in advanced renal failure. Clinical Pharmacology and Therapeutics 16(4): 659-666

Prandota, J.; Houin, G.; Banaszak, A.; Tillement, J.P. 1983: Pharmacokinetics of furosemide in infants with pneumonia and/or other diseases. Pediatria Polska 58(4): 353-360

Hammarlund, M.M.; Paalzow, L.K.; Odlind, B. 1984: Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis. European Journal of Clinical Pharmacology 26(2): 197-207

Vert, P.; Broquaire, M.; Legagneur, M.; Morselli, P.L. 1982: Pharmacokinetics of furosemide in neonates. European Journal of Clinical Pharmacology 22(1): 39-45

Cutler, R.E.; Forrey, A.W.; Christopher, T.G.; Kimpel, B.M. 1974: Pharmacokinetics of furosemide in normal subjects and functionally anephric patients. Clinical Pharmacology and Therapeutics 15(6): 588-596

González, G.; Arancibia, A.; Rivas, M.I.; Caro, P.; Antezana, C. 1982: Pharmacokinetics of furosemide in patients with hepatic cirrhosis. European Journal of Clinical Pharmacology 22(4): 315-320

Juhn, S.K.; Rybak, L.P.; Morizono, T.; Green, L.P. 1981: Pharmacokinetics of furosemide in relation to the alteration of endocochlear potential. Scandinavian Audiology. Supplementum 14(Suppl): 39-49

Prandota, J. 1983: Pharmacokinetics of furosemide urinary elimination by nephrotic children. Pediatric Research 17(2): 141-147

Kelsen, D.P.; Alcock, N.; Yeh, S.; Brown, J.; Young, C. 1980: Pharmacokinetics of gallium nitrate in man. Cancer 46(9): 2009-2013

Modr, Z.; Dvorácek, K. 1970: Pharmacokinetics of gentamicin. Casopis Lekaru Ceskych 109(17): 388-393

Danish, M.; Schultz, R.; Jusko, W.J. 1974: Pharmacokinetics of gentamicin and kanamycin during hemodialysis. Antimicrobial Agents and ChemoTherapy 6(6): 841-847

Kliegman, R.M.; Bertino, J.S.; Fanaroff, A.A.; Gavan, T.L.; Speck, W.T. 1980: Pharmacokinetics of gentamicin during exchange transfusions in neonates. Journal of Pediatrics 96(5): 927-930

Simon, C.; Schmitt, E.; Malerczyk, V.; Arkenau, C. 1973: Pharmacokinetics of gentamicin in adults and children of various ages. Die Medizinische Welt 24(16): 626-630

Bird, J.E.; Miller, K.W.; Larson, A.A.; Duke, G.E. 1983: Pharmacokinetics of gentamicin in birds of prey. American Journal of Veterinary Research 44(7): 1245-1247

Pancorbo, S.; Comty, C. 1981: Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrobial Agents and ChemoTherapy 19(4): 605-607

Segal, J.L.; Gray, D.R.; Gordon, S.K.; Eltorai, I.M.; Khonsari, F. 1984: Pharmacokinetics of gentamicin in patients with spinal cord injury. Clinical Pharmacy 3(4): 418-420

Tran Ba Huy, P.; Manuel, C.; Meulemans, A.; Sterkers, O.; Amiel, C. 1981: Pharmacokinetics of gentamicin in perilymph and endolymph of the rat as determined by radioimmunoassay. Journal of Infectious Diseases 143(3): 476-486

Von Kobyletzki, D.; Wahlig, H.; Gebhardt, F. 1969: Pharmacokinetics of gentamicin in serum and urine. Medizinische Klinik 64(34): 1497-1502

Petitjean, A.; Astier, A.; Louchahi, M.; Perret, G.; Karsenti, P.; Jacquot, C.; Petitjean, O. 1983: Pharmacokinetics of gentamicin in the decompensed alcoholic cirrhotic patient. Therapeutic consequences. Pathologie-Biologie 31(5): 399-403

Pedersoli, W.M.; Belmonte, A.; Purohit, R.C.; Ravis, W.R. 1980: Pharmacokinetics of gentamicin in the horse. American Journal of Veterinary Research 41(3): 351-354

Riviere, J.E.; Coppoc, G.L. 1981: Pharmacokinetics of gentamicin in the juvenile dog. American Journal of Veterinary Research 42(9): 1621-1623

Hindmarsh, K.W.; Nation, R.L.; Williams, G.L.; John, E.; French, J.N. 1983: Pharmacokinetics of gentamicin in very low birth weight preterm infants. European Journal of Clinical Pharmacology 24(5): 649-653

Gyselynck, A.M.; Forrey, A.; Cutler, R. 1971: Pharmacokinetics of gentamicin: distribution and plasma and renal clearance. Journal of Infectious Diseases 124(Suppl): S70-S76

Lesne, M.; Jacqmin, P.; El Allaf, D.; Carlier, J. 1982: Pharmacokinetics of gitaloxin in healthy man and in the renal insufficiency patient. Therapie 37(6): 641-644

Dei Cas, L.; Vasini, G.; Manca, C.; Buia, E.; Pelagatti, T.; Bernardini, B. 1981: Pharmacokinetics of gitoformate in subjects with renal insufficiency under dialysis treatment. Bollettino Della Societa Italiana di Cardiologia 26(12): 2381-2382

Rentsch, G.; Schmidt, H.A.; Rieder, J. 1972: Pharmacokinetics of glibornuride. Arzneimittel-Forschung 22:Suppl.12a: 2209

Midha, K.K.; Roscoe, R.M.; Wilson, T.W.; Cooper, J.K.; Loo, J.C.; Ho-Ngoc, A.; McGilveray, I.J. 1983: Pharmacokinetics of glucuronidation of propranolol following oral administration in humans. Biopharmaceutics and Drug Disposition 4(4): 331-338

Belkina, Z.V.; Kobzeva, N.A.; Uzbekova, D.G. 1981: Pharmacokinetics of glutathione after intraperitoneal administration. Farmakologiia i Toksikologiia 44(5): 622-624

Held, H.; Eisert, R.; von Oldershausen, H.F. 1973: Pharmacokinetics of glymidine (glycodiazine) and tolbutamide in acute and chronic liver diseases. Arzneimittel-Forschung 23(12): 1801-1807

Walz, D.T.; Griswold, D.E.; DiMartino, M.J.; Bumbier, E.E. 1980: Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats. Journal of Rheumatology 7(6): 820-824

Gottlieb, N.L.; Gray, R.G. 1981: Pharmacokinetics of gold in rheumatoid arthritis. Agents and Actions. Supplements 8: 529-538

Waller, E.S.; Massarella, J.W.; Crout, J.E.; Yakatan, G.J. 1982: Pharmacokinetics of gold sodium thiomalate. Research Communications in Chemical Pathology and Pharmacology 37(1): 33-47

Handelsman, D.J.; Jansen, R.P.; Boylan, L.M.; Spaliviero, J.A.; Turtle, J.R. 1984: Pharmacokinetics of gonadotropin-releasing hormone: comparison of subcutaneous and intravenous routes. Journal of Clinical Endocrinology and Metabolism 59(4): 739-746

Mattila, J.; Mäntylä, R.; Vuorela, A.; Lamminsivu, U.; Männistö, P. 1984: Pharmacokinetics of graded oral doses of sulindac in man. Arzneimittel-Forschung 34(2): 226-229

Gerber, N.; Seibert, R.; Desiderio, D.; Thompson, R.M.; Lane, M. 1973: Pharmacokinetics of guanazole in man. Clinical Pharmacology and Therapeutics 14(2): 264-270

Kirch, W.; Kohler, H.; Axthelm, T. 1982: Pharmacokinetics of guanfacine in patients undergoing haemodialysis. European Journal of Drug Metabolism and Pharmacokinetics 7(4): 277-280

Barber, N.D.; Reid, J.L. 1983: Pharmacokinetics of guanfacine in the rabbit. Journal of Pharmacy and Pharmacology 35(2): 114-115

Martín-Larrauri, R. 1995: Pharmacokinetics of halogenated inhalation anesthetics. Revista Espanola de Anestesiologia y Reanimacion 42(6): 236-245

Reyntigens, A.J.; Heykants, J.J.; Woestenborghs, R.J.; Gelders, Y.G.; Aerts, T.J. 1982: Pharmacokinetics of haloperidol decanoate. a 2-year follow-up. International Pharmacopsychiatry 17(4): 238-246

Mark, L.C.; Geddes, I.C.; Scherrer, J.R.; Dombrowski, C.S.; Cohn, S.H. 1971: Pharmacokinetics of halothane in man: a novel approach. International Journal of Applied Radiation and Isotopes 22(3): 171-175

Watari, K. 1993: Pharmacokinetics of hematopoietic growth factors and granulopoiesis. the pathophysiology of human granulocyte colony-stimulating factor. Japanese Journal of Clinical Hematology 34(5): 562-566

Boswell, G.; Rodkey, W.G. 1983: Pharmacokinetics of hemoglobin infusion. Progress in Clinical and Biological Research 122: 139-147

Whitfield, L.R.; Wilkenfeld, C.; Levy, G. 1984: Pharmacokinetics of heparin VII: Effect of pregnancy on the relationship between concentration and anticoagulant action of heparin in rats. Journal of Pharmaceutical Sciences 73(1): 72-74

Metz, J.; Stau, T.; Taugner, R. 1972: Pharmacokinetics of heparin and heparinoids. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 1570-1574

Beermann, B.; Lahnborg, G. 1981: Pharmacokinetics of heparin in healthy and obese subjects and in combination with dihydroergotamine. Thrombosis and Haemostasis 45(1): 24-26

Broggini, M.; Colombo, T.; D'Incalci, M.; Donnelli, M.G.; Gescher, A.; Garattini, S. 1981: Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice. Cancer Treatment Reports 65(7-8): 669-672

Marone, C.; Reubi, F.C.; Perisic, M.; Lahn, W. 1984: Pharmacokinetics of high doses of piretanide in moderate to severe renal failure. European Journal of Clinical Pharmacology 27(5): 589-593

Yacobi, A.; Gibson, T.P.; McEntegart, C.M.; Hulse, J.D. 1982: Pharmacokinetics of high molecular weight hydroxyethyl starch in dogs. Research Communications in Chemical Pathology and Pharmacology 36(2): 199-204

Wilkinson, P.M.; O'Neill, P.A.; Thatcher, N.; Lucas, S.B. 1983: Pharmacokinetics of high-dose cyclophosphamide in patients with metastatic bronchogenic carcinoma. Cancer ChemoTherapy and Pharmacology 11(3): 196-199

Hande, K.R.; Wedlund, P.J.; Noone, R.M.; Wilkinson, G.R.; Greco, F.A.; Wolff, S.N. 1984: Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients. Cancer Research 44(1): 379-382

Cartwright, D.P.; Chapman, J.C.; Davies, J.R.; Scoggins, A.M. 1981: Pharmacokinetics of high-dose fentanyl. British Journal of Anaesthesia 53(7): 780

Bovill, J.G.; Sebel, P.S. 1980: Pharmacokinetics of high-dose fentanyl. a study in patients undergoing cardiac surgery. British Journal of Anaesthesia 52(8): 795-801

Koska, A.J.; Kramer, W.G.; Romagnoli, A.; Keats, A.S.; Sabawala, P.B. 1981: Pharmacokinetics of high-dose meperidine in surgical patients. Anesthesia and Analgesia 60(1): 8-11

Porpaczy, P.; Schmidbauer, C.P.; Georgopoulos, A.; Endler, A.T. 1983: Pharmacokinetics of high-dose methotrexate in dogs. An experimental model with diffusion chambers. Cancer ChemoTherapy and Pharmacology 11(3): 172-176

Stanski, D.R.; Mihm, F.G.; Rosenthal, M.H.; Kalman, S.M. 1980: Pharmacokinetics of high-dose thiopental used in cerebral resuscitation. Anesthesiology 53(2): 169-171

Rüdell, E.; Bonte, W.; Sprung, R.; Kühnholz, B. 1983: Pharmacokinetics of higher alphatic alcohols. Beitrage Zur Gerichtlichen Medizin 41: 211-218

DiSanto, A.R.; Wagner, J.G. 1972: Pharmacokinetics of highly ionized drugs. 3. Methylene blue--blood levels in the dog and tissue levels in the rat following intravenous administration. Journal of Pharmaceutical Sciences 61(7): 1090-1094

DiSanto, A.R.; Wagner, J.G. 1972: Pharmacokinetics of highly ionized drugs. I. Methylene blue--whole blood, urine, and tissue assays. Journal of Pharmaceutical Sciences 61(4): 598-602

DiSanto, A.R.; Wagner, J.G. 1972: Pharmacokinetics of highly ionized drugs. II. Methylene blue--absorption, metabolism, and excretion in man and dog after oral administration. Journal of Pharmaceutical Sciences 61(7): 1086-1090

Hirsch, M.S.; Tolkoff-Rubin, N.E.; Kelly, A.P.; Rubin, R.H. 1983: Pharmacokinetics of human and recombinant leukocyte interferon in patients with chronic renal failure who are undergoing hemodialysis. Journal of Infectious Diseases 148(2): 335

Satoh, Y.; Kasama, K.; Usuki, K.; Naruse, N.; Ida, N. 1984: Pharmacokinetics of human fibroblast interferon in rats. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(2): 301-306

Frier, B.M.; Sullivan, F.M.; Mair, F.S.; Koch, I.M.; Scotton, J.B. 1984: Pharmacokinetics of human insulin zinc suspension (recombinant DNA) in normal man: a comparison with porcine insulin zinc suspension. Diabetic Medicine: a Journal of the British Diabetic Association 1(3): 219-221

Hilfenhaus, J.; Damm, H.; Hofstaetter, T.; Mauler, R.; Ronneberger, H.; Weinmann, E. 1981: Pharmacokinetics of human interferon-beta in monkeys. Journal of Interferon Research 1(3): 427-436

Furue, H.; Kobayashi, H.; Komuro, T.; Kako, M.; Mugitani, H.; Fuse, K.; Kaise, R.; Nagai, K.; Takahashi, T.; Hirota, F. 1984: Pharmacokinetics of human interferons. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(4): 935-942

Gomi, K.; Morimoto, M.; Inoue, A.; Kobayashi, H.; Deguchi, T.; Hara, T.; Nakamizo, N. 1984: Pharmacokinetics of human recombinant interferon-beta in monkeys and rabbits. Gan 75(3): 292-300

Shen, D.D.; Hosler, J.P.; Schroder, R.L.; Azarnoff, D.L. 1980: Pharmacokinetics of hydralazine and its acid-labile hydrazone metabolites in relation to acetylator phenotype. Journal of Pharmacokinetics and Biopharmaceutics 8(1): 53-68

Holt, R.J.; Gaskins, J.D. 1983: Pharmacokinetics of hydralazine and the first pass effect. Boletin de la Asociacion Medica de Puerto Rico 75(6): 276-279

Filov, V.A.; Popov, B.V.; Bezel', V.S. 1982: Pharmacokinetics of hydrazine sulfate in intact and tumor-bearing rats. Farmakologiia i Toksikologiia 45(4): 78-81

Barbhaiya, R.H.; Craig, W.A.; Corrick-West, H.P.; Welling, P.G. 1982: Pharmacokinetics of hydrochlorothiazide in fasted and nonfasted subjects: a comparison of plasma level and urinary excretion methods. Journal of Pharmaceutical Sciences 71(2): 245-248

Niemeyer, C.; Hasenfuss, G.; Wais, U.; Knauf, H.; Schäfer-Korting, M.; Mutschler, E. 1983: Pharmacokinetics of hydrochlorothiazide in relation to renal function. European Journal of Clinical Pharmacology 24(5): 661-665

Brørs, O. 1982: Pharmacokinetics of hydroflumethiazide during repeated administration in congestive heart failure. Acta Pharmacologica et Toxicologica 51(3): 177-181

Yacobi, A.; Stoll, R.G.; Sum, C.Y.; Lai, C.M.; Gupta, S.D.; Hulse, J.D. 1982: Pharmacokinetics of hydroxyethyl starch in normal subjects. Journal of Clinical Pharmacology 22(4): 206-212

Adamska-Dyniewska, H.; Tkaczewski, W.; Michowicz, A.; Wichan, P. 1982: Pharmacokinetics of hymecromone (Cholestil) in various liver and biliary tract diseases. Polski Tygodnik Lekarski 37(37): 1085-1087

Staffeldt, B.; Kerb, R.; Brockmöller, J.; Ploch, M.; Roots, I. 1994: Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract Li 160 in healthy volunteers. Journal of Geriatric Psychiatry and Neurology 7(Suppl 1): S47-S53

Workman, P. 1980: Pharmacokinetics of hypoxic cell radiosensitizers: a review. Cancer Clinical Trials 3(3): 237-251

Albert, K.S.; Gernaat, C.M. 1984: Pharmacokinetics of ibuprofen. American Journal of Medicine 77(1a): 40-46

Lockwood, G.F.; Albert, K.S.; Szpunar, G.J.; Wagner, J.G. 1983: Pharmacokinetics of ibuprofen in man--III: Plasma protein binding. Journal of Pharmacokinetics and Biopharmaceutics 11(5): 469-482

Plempel, M. 1980: Pharmacokinetics of imidazole-antimycotics. Mykosen 23(1): 16-27

Abdullah, A.S.; Baggot, J.D. 1983: Pharmacokinetics of imidocarb in normal dogs and goats. Journal of Veterinary Pharmacology and Therapeutics 6(3): 195-199

Norrby, S.R.; Björnegård, B.; Ferber, F.; Jones, K.H. 1983: Pharmacokinetics of imipenem in healthy volunteers. Journal of Antimicrobial ChemoTherapy 12 Suppl D: 109-124

Szymura-Oleksiak, J.; Panas, M.; Chruściel, W. 1983: Pharmacokinetics of imipramine after single and multiple intravenous administration in rats. Polish Journal of Pharmacology and Pharmacy 35(2): 151-157

Grebow, P.E.; Treitman, J.A. 1981: Pharmacokinetics of indapamide in dogs. Journal of Pharmaceutical Sciences 70(12): 1310-1312

Sartoris, D.J.; Goodwin, D.A.; Meares, C.F.; DeRiemer, L.H.; Fajardo, L.F. 1984: Pharmacokinetics of indium-111 BLEDTA in man. Investigative Radiology 19(3): 221-227

Yates, M.S.; Emmerson, J.; Bowmer, C.J. 1983: Pharmacokinetics of indocyanine green in rats with chronic renal failure. Journal of Pharmacy and Pharmacology 35(9): 593-594

Dittrich, P.; Köhler, G.; Primbs, P.; Kukovetz, W.R. 1984: Pharmacokinetics of indomethacin I.m. in blood, synovial fluid, synovial membrane, muscle, fat, bone, and spinal fluid. European Journal of Rheumatology and Inflammation 7(2): 45-50

Traeger, A.; Stein, G.; Kunze, M.; Zaumseil, J. 1972: Pharmacokinetics of indomethacin in patients with kidney lesions. International Journal of Clinical Pharmacology Therapy and Toxicology 6(3): 237-242

Traeger, A.; Nöschel, H.; Zaumseil, J. 1973: Pharmacokinetics of indomethacin in pregnant and parturient women and in their newborn infants. Zentralblatt für Gynakologie 95(1): 635-641

Traeger, A.; Kunze, M.; Stein, G.; Ankermann, H. 1973: Pharmacokinetics of indomethacin in the aged. Zeitschrift für Alternsforschung 27(2): 151-155

Brash, A.R.; Hickey, D.E.; Graham, T.P.; Stahlman, M.T.; Oates, J.A.; Cotton, R.B. 1981: Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus. New England Journal of Medicine 305(2): 67-72

Bianchetti, G.; Monin, P.; Marchal, F.; Dubruc, C.; Boutroy, M.J.; Morselli, P.L.; Vert, P. 1980: Pharmacokinetics of indomethacin in the premature infant. Developmental Pharmacology and Therapeutics 1(2-3): 111-124

Kershaw, R.A.; Staubus, A.; Sharp, D.E.; Bianchine, J.; Gerber, N. 1983: Pharmacokinetics of indoprofen (4-[1,3-dihydro-1-oxo-2H-isoindol-2-yl)-alpha-methylbenzene acetic acid) in the rat: influence of exteriorization of the bile duct and explanation of selective toxicity in the rat. Proceedings of the Western Pharmacology Society 26: 397-401

Gonçalves, B. 1970: Pharmacokinetics of inhalation anesthetics. Revista Brasileira de Anestesiologia 20(2): 237-263

Tanner, G. 1982: Pharmacokinetics of inhalation anesthetics: a three-compartment linear model. Anesthesia and Analgesia 61(7): 587-594

Nolan, R.J.; Unger, S.M.; Muller, C.J. 1982: Pharmacokinetics of inhaled [14C]-2-nitropropane in male Sprague-Dawley rats. Ecotoxicology and Environmental Safety 6(4): 388-397

Parmentier, P. 1985: Pharmacokinetics of inhaled anesthetic agents. Annales Francaises d'Anesthesie et de Reanimation 4(6): 98a

Andersen, M.E. 1981: Pharmacokinetics of inhaled gases and vapors. Neurobehavioral Toxicology and Teratology 3(4): 383-389

Evans, M.E.; Paterson, J.W.; Richards, A.J.; Walker, S.R. 1971: Pharmacokinetics of inhaled salbutamol in asthmatic patients. British Journal of Pharmacology 43(2): 466P-467P

Lambe, C.U.; Nelson, D.J. 1982: Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice. Biochemical Pharmacology 31(4): 535-539

Berman, W.; Friedman, Z.; Vidyasagar, D. 1980: Pharmacokinetics of inhibitors of prostaglandin synthesis in the perinatal period. Seminars in Perinatology 4(1): 67-72

Nagataki, S.; Mishima, S. 1980: Pharmacokinetics of instilled drugs in the human eye. International Ophthalmology Clinics 20(3): 33-49

Bottermann, P.; Gyaram, H.; Wahl, K.; Ermler, R.; Lebender, A. 1981: Pharmacokinetics of insulin administered intraperitoneal in a bolus form. Klinische Wochenschrift 59(4): 157-163

Shima, K.; Ikegami, H.; Tahara, Y.; Hirota, M.; Tanaka, A.; Kumahara, Y. 1984: Pharmacokinetics of insulin and glucagon injected subcutaneously in the elderly. Medical Journal of Osaka University 34(3-4): 87-93

Dreval', A.V. 1982: Pharmacokinetics of insulin and glucose during insulin infusions to diabetes patients. I. Basal regimen. Meditsinskaia Tekhnika 6: 21-26

Williams, B.B.; Paul, R.T.; Lerner, A.M. 1982: Pharmacokinetics of interferon in blood, cerebrospinal fluid, and brain after administration of modified polyriboinosinic-polyribocytidylic acid and amphotericin B. Journal of Infectious Diseases 146(6): 819-825

Bocci, V. 1981: Pharmacokinetics of interferons. a reappraisal. Texas Reports on Biology and Medicine 41: 336-343

Montero-Julian, F.A.; Gautherot, E.; Wijdenes, J.; Klein, B.; Brailly, H. 1994: Pharmacokinetics of interleukin-6 during therapy with anti-interleukin-6 monoclonal antibodies: enhanced clearance of interleukin-6 by a combination of three anti-interleukin-6 antibodies. Journal of Interferon Research 14(5): 301-302

Stephens, F.O. 1983: Pharmacokinetics of intra-arterial chemotherapy. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 86: 1-12

Von Scheel, J.; Golde, G. 1984: Pharmacokinetics of intra-arterial tumour therapy. An experimental study. Archives of Oto-Rhino-Laryngology 239(2): 153-161

Hu, E.; Howell, S.B. 1983: Pharmacokinetics of intraarterial mitomycin C in humans. Cancer Research 43(9): 4474-4477

Dajani, A.S.; Thirumoorthi, M.C.; Bawdon, R.E.; Buckley, J.A.; Pfeffer, M.; Van Harken, D.R.; Smyth, R.D. 1982: Pharmacokinetics of intramuscular ceforanide in infants, children, and adolescents. Antimicrobial Agents and ChemoTherapy 21(2): 282-287

Brogard, J.M.; Comte, F.; Kopferschmitt, J.; Dorner, M.; Lavillaureix 1982: Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function. La Nouvelle Presse Medicale 11(5 Part 2): 340-346

Schwagmeier, R.; Boerger, N.; Meissner, W.; Striebel, H.W. 1995: Pharmacokinetics of intranasal alfentanil. Journal of Clinical Anesthesia 7(2): 109-113

Phillpotts, R.J.; Davies, H.W.; Willman, J.; Tyrrell, D.A.; Higgins, P.G. 1984: Pharmacokinetics of intranasally applied medication during a cold. Antiviral Research 4(1-2): 71-74

Huang, T.Y.; Arita, N.; Ushio, Y.; Hayakawa, T.; Yamada, K. 1994: Pharmacokinetics of intrathecal 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in rats. Journal of Neuro-Oncology 19(3): 245-250

Fujimoto, T. 1984: Pharmacokinetics of intrathecal chemotherapy and clinical problems. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(8): 1536-1542

Pinaud, M.; Meignier, M.; Kergueris, M.F.; Le Normand, Y.; Lasserre, M.P.; Souron, R.; Larousse, C. 1984: Pharmacokinetics of intravenous and intramuscular methohexitone in dogs. European Journal of Anaesthesiology 1(1): 55-62

La Greca, G.; Biasioli, S.; Chiaramonte, S.; Fabris, A.; Feriani, M.; Pisani, E.; Ronco, C.; Xerri, L. 1982: Pharmacokinetics of intravenous and intraperitoneal cefuroxime during peritoneal dialysis. International Journal of Clinical Pharmacology Therapy and Toxicology 20(2): 92-94

Local, F.K.; Munro, A.J.; Kerr, D.N.; Sussman, M. 1981: Pharmacokinetics of intravenous and intraperitoneal cefuroxime in patients undergoing peritoneal dialysis. Clinical Nephrology 16(1): 40-43

Rowell, F.J.; Seymour, R.A.; Rawlins, M.D. 1983: Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites. European Journal of Clinical Pharmacology 25(3): 419-424

Abshagen, U.; Betzien, G.; Endele, R.; Kaufmann, B. 1981: Pharmacokinetics of intravenous and oral isosorbide - 5 - mononitrate. European Journal of Clinical Pharmacology 20(4): 269-275

Al-Habet, S.; Rogers, H.J. 1980: Pharmacokinetics of intravenous and oral prednisolone. British Journal of Clinical Pharmacology 10(5): 503-508

Lloyd-Jones, J.G.; Henson, R.; Nichols, J.D.; Greenslade, D.; Clifford, J.M. 1981: Pharmacokinetics of intravenous and oral tolmesoxide. European Journal of Clinical Pharmacology 19(2): 119-125

Aoki, Y.; Tashiro, C. 1982: Pharmacokinetics of intravenous buprenorphine in patients anesthetized with N2O-buprenorphine. Masui. Japanese Journal of Anesthesiology 31(2): 129-132

Legheand, J.; Cuisinaud, G.; Bernard, N.; Riotte, M.; Sassard, J. 1982: Pharmacokinetics of intravenous camazepam in dogs. Arzneimittel-Forschung 32(7): 752-756

Chodos, J.; Francke, E.L.; Saltzman, M.; Neu, H.C. 1981: Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis. Therapeutic Drug Monitoring 3(1): 71-74

Burke, J.T.; Wargin, W.A.; Sherertz, R.J.; Sanders, K.L.; Blum, M.R.; Sarubbi, F.A. 1982: Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic function. Journal of Pharmacokinetics and Biopharmaceutics 10(6): 601-614

Thompson, J.A.; Bloedow, D.C.; Leffert, F.H. 1981: Pharmacokinetics of intravenous chlorpheniramine in children. Journal of Pharmaceutical Sciences 70(11): 1284-1286

Yee, G.C.; Kennedy, M.S.; Storb, R.; Thomas, E.D. 1984: Pharmacokinetics of intravenous cyclosporine in bone marrow transplant patients. Comparison of two assay methods. Transplantation 38(5): 511-513

Parsons, R.L.; David, J.A.; Raymond, K.; Stamp, S.M. 1980: Pharmacokinetics of intravenous erythromycin lactobionate. Journal of International Medical Research 8(Suppl 2): 15-23

Rogers, H.J.; Spector, R.G.; Morrison, P.J.; Bradbrook, I.D. 1982: Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay. Diabetologia 23(1): 37-40

Norbury, H.M.; Franklin, R.A.; Marrott, P.K.; Warrington, S.J. 1983: Pharmacokinetics of intravenous indoramin in middle-aged male and female volunteers. European Journal of Clinical Pharmacology 25(2): 243-246

Platzer, R.; Reutemann, G.; Galeazzi, R.L. 1982: Pharmacokinetics of intravenous isosorbide-dinitrate. Journal of Pharmacokinetics and Biopharmaceutics 10(6): 575-586

Hermann, T.; Skibińska, L.; Szwarc, E.; Michalewska, D. 1984: Pharmacokinetics of intravenous methotrexate in children with neoplasms of the hematopoietic system. Polski Tygodnik Lekarski 39(21): 713-716

Gjerløff, C.; Arnold, E. 1982: Pharmacokinetics of intravenous metronidazole in man. Acta Pharmacologica et Toxicologica 51(2): 132-135

Pentikäinen, P.J.; Halinen, M.O.; Helin, M.J. 1984: Pharmacokinetics of intravenous mexiletine in patients with acute myocardial infarction. Journal of Cardiovascular Pharmacology 6(1): 1-6

Cano, J.P.; Rigault, J.P.; Gevaudan, M.J.; Saingra, S.; Murisasco, A.; Charpin, J. 1982: Pharmacokinetics of intravenous mezlocillin in patients with normal and impaired renal function. La Nouvelle Presse Medicale 11(5 Part 2): 335-339

Vandenberghe, H.; Mac Leod, S.; Chinyanga, H.; Endrenyi, L.; Soldin, S. 1983: Pharmacokinetics of intravenous morphine in balanced anesthesia: studies in children. Drug Metabolism Reviews 14(5): 887-903

Murphy, M.R.; Hug, C.C. 1981: Pharmacokinetics of intravenous morphine in patients anesthetized with enflurane-nitrous oxide. Anesthesiology 54(3): 187-192

Rietbrock, I. 1981: Pharmacokinetics of intravenous narcotics (barbiturates and fentanyl) anesthesia and intensive care in patients with liver and kidney insufficiency. Klinische Anasthesiologie und Intensivtherapie 23: 59-70

Kienlen, J.; Chardon, P. 1981: Pharmacokinetics of intravenous non-steroidal anesthetics. Annales de l'Anesthesiologie Francaise 22(2): 129-141

Bretagne, J.F.; Reymann, J.M.; Tassou, J.J.; Allain, H.; Gosselin, A.; Gastard, J. 1983: Pharmacokinetics of intravenous ranitidine and its effect on gastric acid secretion stimulated by pentagastrin in the cirrhotic. Gastroenterologie Clinique et Biologique 7(4): 355-361

Di Nola, F.; Eandi, M.; Soranzo, M.L.; Capra, E.; Bosio, G.; Bramato, C.; Salassa, B.; Bendiscioli, L. 1981: Pharmacokinetics of intravenous rifampicin (RMP) and its clinical evaluation in purulent bacterial meningitis. Minerva Medica 72(14): 875-892

Mitenko, P.A.; Ogilvie, R.I. 1973: Pharmacokinetics of intravenous theophylline. Clinical Pharmacology and Therapeutics 14(4): 509-513

Siber, G.R.; Gorham, C.C.; Ericson, J.F.; Smith, A.L. 1982: Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function. Reviews of Infectious Diseases 4(2): 566-578

Rao, M.; Steiner, P.; Victoria, M.S.; Jabbar, H.; Maraya, R. 1982: Pharmacokinetics of intravenously administered aminophylline in children. Journal of Asthma: Official Journal of the Association for the Care of Asthma 19(1): 39-41

Pentikäinen, P.J.; Neuvonen, P.J.; Kekki, M.; Penttilä, A. 1980: Pharmacokinetics of intravenously administered bumetanide in man. Journal of Pharmacokinetics and Biopharmaceutics 8(3): 219-228

Wise, R.; Lockley, R.M.; Webberly, M.; Dent, J. 1984: Pharmacokinetics of intravenously administered ciprofloxacin. Antimicrobial Agents and ChemoTherapy 26(2): 208-210

Verma, P.S.; Hoyt, R.F.; Jackson, A.J.; Phillips, Y.Y. 1984: Pharmacokinetics of intravenously administered desmosine in sheep. Connective Tissue Research 12(3-4): 191-195

Thalji, A.A.; Carr, I.; Yeh, T.F.; Raval, D.; Luken, J.A.; Pildes, R.S. 1980: Pharmacokinetics of intravenously administered indomethacin in premature infants. Journal of Pediatrics 97(6): 995-1000

Thirumoorthi, M.C.; Asmar, B.I.; Buckley, J.A.; Bollinger, R.O.; Kauffman, R.E.; Dajani, A.S. 1983: Pharmacokinetics of intravenously administered piperacillin in preadolescent children. Journal of Pediatrics 102(6): 941-946

Collins, J.M. 1983: Pharmacokinetics of intraventricular administration. Journal of Neuro-Oncology 1(4): 283-291

Barza, M.; Kane, A.; Baum, J. 1983: Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys. Investigative Ophthalmology and Visual Science 24(12): 1602-1606

Jack, D.B.; Riess, W. 1973: Pharmacokinetics of iodochlorhydroxyquin in man. Journal of Pharmaceutical Sciences 62(12): 1929-1932

Edelson, J.; Shaw, D.; Palace, G. 1984: Pharmacokinetics of iohexol, a new nonionic radiocontrast agent, in humans. Journal of Pharmaceutical Sciences 73(7): 993-995

Mützel, W.; Speck, U.; Weinmann, H.J. 1983: Pharmacokinetics of iopromide in rat and dog. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband 118: 85-90

Gaitondé, B.B.; Vakil, B.J.; Samuel, M.R.; Chabria, N.L.; Kamath, R.A. 1972: Pharmacokinetics of iron absorption with a new iron preparation. Indian Journal of Medical Research 60(11): 1674-1681

Wichliński, L.; Wiezowska, B.; Krzyśko, K. 1981: Pharmacokinetics of iron ions. Acta Poloniae Pharmaceutica 38(2): 243-248

Georgieva, R.; Ognianova, V.; Velikova, E.; Naplatanova, D.; Mikhaĭlova, D. 1984: Pharmacokinetics of isodinit (from Pharmachem) in humans. Eksperimentalna Meditsina i Morfologiia 23(3): 138-143

Titarenko, O.T.; Vakhmistrova, T.I.; Perova, T.L.; Morozov, N.V. 1983: Pharmacokinetics of isoniazid in chronic kidney failure. Vrachebnoe Delo 4: 19-22

Advenier, C.; Saint-Aubin, A.; Gobert, C.; Houin, G.; Albengres, E.; Tillement, J.P. 1980: Pharmacokinetics of isoniazid in the elderly. British Journal of Clinical Pharmacology 10(2): 167-169

Junosza-Szaniawska, J.; Wierzba, K. 1980: Pharmacokinetics of isonicotinic acid hydrazide (INH) in the body of pregnant rats. Acta Poloniae Pharmaceutica 37(6): 693-698

Assandri, A.; Bernareggi, A.; Morrone, A.; Odasso, G. 1984: Pharmacokinetics of isoprazone, a new analgesic antipyretic agent, in the rat. Il Farmaco; Edizione Pratica 39(4): 118-130

Frydman, A.; Levenson, J.; Simon, A.; Safar, M.; Bieder, A.; Bertharion, J.; Gaillot, J. 1982: Pharmacokinetics of isosorbide dinitrate administered by intravenous infusion to hypertensive patients. La Nouvelle Presse Medicale 11(27): 2049-2056

Taylor, T.; Chasseaud, L.F.; Doyle, E.; Darragh, A.; O'Kelly, D.A.; Fitzgerald, D. 1980: Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects. Biopharmaceutics and Drug Disposition 1(3): 149-156

Doyle, E.; Chasseaud, L.F. 1981: Pharmacokinetics of isosorbide dinitrate in rhesus monkey, cynomolgus monkey, and baboon. Journal of Pharmaceutical Sciences 70(11): 1270-1272

Steudel, H.C.; Volkenandt, M.; Steudel, A.T. 1983: Pharmacokinetics of isosorbide-5-mononitrate after oral and intravenous administration in patients with liver cirrhosis: first results. Zeitschrift für Kardiologie 72(Suppl 3): 24-28

Kösters, W.; Klotschkoff, P.; Abshagen, U. 1981: Pharmacokinetics of isosorbide-5-mononitrate in patients with advanced renal failure. Die Medizinische Welt 32(14a): 521-523

Colburn, W.A.; Vane, F.M.; Shorter, H.J. 1983: Pharmacokinetics of isotretinoin and its major blood metabolite following a single oral dose to man. European Journal of Clinical Pharmacology 24(5): 689-694

Brazzell, R.K.; Vane, F.M.; Ehmann, C.W.; Colburn, W.A. 1983: Pharmacokinetics of isotretinoin during repetitive dosing to patients. European Journal of Clinical Pharmacology 24(5): 695-702

Khoo, K.C.; Reik, D.; Colburn, W.A. 1982: Pharmacokinetics of isotretinoin following a single oral dose. Journal of Clinical Pharmacology 22(8-9): 395-402

Kölle, E.U.; Hengy, H.; Vollmer, K.O. 1983: Pharmacokinetics of isoxicam in man following oral administration. Arzneimittel-Forschung 33(4): 582-586

Okolicsanyi, L.; Miglioli, P.A.; Venuti, M.; Orlando, R.; Iemmolo, R.M.; Festa, A.; Grollo, A.; Berti, T. 1982: Pharmacokinetics of josamycin in liver cirrhosis. Giornale Italiano di Chemioterapia 29(Suppl 1): 171-174

Fraschini, F.; Braga, P.C.; Gagliardi, V.; Falchi, M.; Scaglione, F.; Scarpazza, G.; Manganelli, V. 1982: Pharmacokinetics of josamycin in man and distribution in various compartments. Giornale Italiano di Chemioterapia 29(Suppl 1): 69-76

Kaka, J.S.; Hayton, W.L. 1980: Pharmacokinetics of ketamine and two metabolites in the dog. Journal of Pharmacokinetics and Biopharmaceutics 8(2): 193-202

Geisslinger, G.; Hering, W.; Kamp, H.D.; Vollmers, K.O. 1995: Pharmacokinetics of ketamine enantiomers. British Journal of Anaesthesia 75(4): 506-507

Reimann, I.W.; Okonkwo, P.O.; Klotz, U. 1983: Pharmacokinetics of ketanserin in man. European Journal of Clinical Pharmacology 25(1): 73-76

Maksymiuk, A.W.; Levine, H.B.; Bodey, G.P. 1982: Pharmacokinetics of ketoconazole in patients with neoplastic diseases. Antimicrobial Agents and ChemoTherapy 22(1): 43-46

Ishizaki, T.; Sasaki, T.; Suganuma, T.; Horai, Y.; Chiba, K.; Watanabe, M.; Asuke, W.; Hoshi, H. 1980: Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration. European Journal of Clinical Pharmacology 18(5): 407-414

Stafanger, G.; Larsen, H.W.; Hansen, H.; Sørensen 1981: Pharmacokinetics of ketoprofen in patients with chronic renal failure. Scandinavian Journal of Rheumatology 10(3): 189-192

Stafanger, G.; Larsen, H.W.; Hansen, H.; Serensen, K. 1983: Pharmacokinetics of ketoprofen in patients with renal failure. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(46): 3191-3193

Advenier, C.; Roux, A.; Gobert, C.; Massias, P.; Varoquaux, O.; Flouvat, B. 1983: Pharmacokinetics of ketoprofen in the elderly. British Journal of Clinical Pharmacology 16(1): 65-70

Kennedy, A.C. 1983: Pharmacokinetics of ketoprofen in the synovial fluid. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(46): 3208-3209

Terao, N.; Shen, D.D. 1984: Pharmacokinetics of l-propranolol during repetitive dosing in normal and uranyl nitrate-induced renal failure rats. Journal of Pharmacokinetics and Biopharmaceutics 12(5): 479-493

Kanto, J.; Allonen, H.; Kleimola, T.; Mäntylä, R. 1981: Pharmacokinetics of labetalol in healthy volunteers. International Journal of Clinical Pharmacology Therapy and Toxicology 19(1): 41-44

Rudzit, E.A.; Nefedova, Z.V. 1969: Pharmacokinetics of larger doses of penicillin. Antibiotiki 14(8): 725-729

Hamel, E.; Johnson, G.; Glaubiger, D. 1981: Pharmacokinetics of leucovorin rescue using a new methotrexate-independent biochemical assay for leucovorin and N5-methyltetrahydrofolate. Cancer Treatment Reports 65(7-8): 545-553

Shepard, R.M. 1981: Pharmacokinetics of levonantradol in laboratory animals and man. Journal of Clinical Pharmacology 21(S1): 190S-200S

Madhavan Nair, K.; Sivakumar, B.; Prema, K.; Narasinga Rao, B.S. 1983: Pharmacokinetics of levonorgestrel in Indian women. European Journal of Clinical Pharmacology 24(2): 255-259

Naqvi, R.H.; Mitra, S.B.; Saksena, I.F.; Lindberg, M.C. 1984: Pharmacokinetics of levonorgestrel in the rat. Contraception 30(1): 81-88

Ben Rhaiem, A.; Nathan, N.; Debord, J.; Lotfi, H.; Lachatre, G.; Feiss, P. 1995: Pharmacokinetics of lidocaine and bupivacaine after peribulbar block with additional hyaluronidase. Annales Francaises d'Anesthesie et de Reanimation 14(2): 162-165

Wilcke, J.R.; Davis, L.E.; Neff-Davis, C.A.; Koritz, G.D. 1983: Pharmacokinetics of lidocaine and its active metabolites in dogs. Journal of Veterinary Pharmacology and Therapeutics 6(1): 49-57

Bennett, P.N.; Aarons, L.J.; Bending, M.R.; Steiner, J.A.; Rowland, M. 1982: Pharmacokinetics of lidocaine and its deethylated metabolite: dose and time dependency studies in man. Journal of Pharmacokinetics and Biopharmaceutics 10(3): 265-281

Jordö, L.; Johnsson, G.; Lundborg, P.; Regårdh, C.G. 1984: Pharmacokinetics of lidocaine in healthy individuals pretreated with multiple doses of metoprolol. International Journal of Clinical Pharmacology Therapy and Toxicology 22(6): 312-315

Boyes, R.N.; Scott, D.B.; Jebson, P.J.; Godman, M.J.; Julian, D.G. 1971: Pharmacokinetics of lidocaine in man. Clinical Pharmacology and Therapeutics 12(1): 105-116

Cusack, B.; Kelly, J.G.; Lavan, J.; Noel, J.; O'Malley, K. 1980: Pharmacokinetics of lignocaine in the elderly. British Journal of Clinical Pharmacology 9(3): 293p-294p

Freise, J.; Mueller, W.H.; Magerstedt, P.; Schmoll, H.J. 1982: Pharmacokinetics of liposome encapsulated cisplatin in rats. Archives Internationales de Pharmacodynamie et de Therapie 258(2): 180-192

Ebadi, M.S.; Simmons, V.J.; Hendrickson, M.J.; Lacy, P.S. 1974: Pharmacokinetics of lithium and its regional distribution in rat brain. European Journal of Pharmacology 27(3): 324-329

Aubry, J.P.; Charpentier, G.; Jaillon, P.; Thomas, M.; Duron, F.; Richard, M.O.; Cheymol, G. 1983: Pharmacokinetics of lithium in hyperthyroid patients. Comparison of results before and after treatment of the acute phase of hyperthyroidism. Therapie 38(1): 39-46

Fyrö, B.; Petterson, U.; Sedvall, G. 1973: Pharmacokinetics of lithium in manic-depressive patients. Acta Psychiatrica Scandinavica 49(3): 237-247

Johnson, G.F.; Hunt, G.E. 1984: Pharmacokinetics of lithium preparations in patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 8(1): 63-70

D'Athis, F.; Desch, G.; Jullien, Y. 1981: Pharmacokinetics of local anesthetics. Annales de l'Anesthesiologie Francaise 22(2): 149-157

Cano, J.P.; Charbit-Bues, M.; Rochaix, T. 1985: Pharmacokinetics of local anesthetics of the amide type. Cahiers d'Anesthesiologie 33(6): 501-507

Segre, G.; Catanese, B. 1981: Pharmacokinetics of lonidamine. ChemoTherapy 27(Suppl): 77-84

Somani, P. 1981: Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disorders. American Journal of Cardiology 48(1): 157-163

Seppänen, J.; Viranta, M.; Julkunen, R.; Wilén, G. 1980: Pharmacokinetics of low dose sulfadiazine in patients with renal failure. Annals of Clinical Research 25: 31-37

Schwarz, J.A.; Koch, W.; Bühler, V.; Kaumeier, S. 1981: Pharmacokinetics of low molecular (monovalent) dextran (Dx 1) in volunteers. International Journal of Clinical Pharmacology Therapy and Toxicology 19(8): 358-367

Feldman, S.; Hayman, L.A.; Hulse, M. 1984: Pharmacokinetics of low- and high-dose intravenous diatrizoate contrast media administration. Investigative Radiology 19(1): 54-57

Allain, P.; Le Bouil, A.; Turcant, A.; Molinier, P.; Armand, P.; Andrianiriana, F. 1994: Pharmacokinetics of low-dose lithium in healthy volunteers. Therapie 49(4): 321-324

Pinkerton, C.R.; Welshman, S.G.; Kelly, J.G.; Shanks, R.G.; Bridges, J.M. 1982: Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia. Cancer ChemoTherapy and Pharmacology 10(1): 36-39

Gambertoglio, J.G.; Barriere, S.L.; Lin, E.T.; Conte, J.E. 1980: Pharmacokinetics of mecillinam in health subjects. Antimicrobial Agents and ChemoTherapy 18(6): 952-956

Løber, J.; Mouridsen, H.T.; Salimtschik, M.; Johansson, E. 1981: Pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular route. Acta Obstetricia et Gynecologica Scandinavica. Suppl 101: 71-74

Fleuren, H.L.; Verwey-van Wissen, C.P.; van Rossum, J.M. 1980: Pharmacokinetics of mefruside and two active metabolites in man. European Journal of Clinical Pharmacology 17(1): 59-69

Taha, I.A.; Ahmad, R.A.; Rogers, D.W.; Pritchard, J.; Rogers, H.J. 1983: Pharmacokinetics of melphalan in children following high-dose intravenous injection. Cancer ChemoTherapy and Pharmacology 10(3): 212-216

Yang, Y.M.; Hoff, C.; Hamm, C.; Mankad, V.; Boerth, R.C.; Friedrich, L. 1995: Pharmacokinetics of meperidine in sickle cell patients. American Journal of Hematology 49(4): 357-358

Mather, L.E.; Bentley, J.B. 1982: Pharmacokinetics of meperidine infusion. Canadian Anaesthetists' Society Journal 29(6): 639-640

Krause, W.; Lennert, C. 1983: Pharmacokinetics of mepindolol administered alone and in combination with hydrochlorothiazide--a bioequivalence study. Biopharmaceutics and Drug Disposition 4(4): 339-345

Krause, W.; Kühne, G. 1983: Pharmacokinetics of mepindolol sulfate in the rat, dog, and rhesus monkey. Studies on species differences. Drug Metabolism and Disposition: the Biological Fate of Chemicals 11(2): 91-96

Krause, W.; Kühne, G.; Täuber, U. 1980: Pharmacokinetics of mepindolol sulphate in animals. European Journal of Drug Metabolism and Pharmacokinetics 5(4): 241-247

Held, H.; von Oldershausen, H.F. 1969: Pharmacokinetics of meprobamate in chronic liver diseases and drug addiction. Klinische Wochenschrift 47(2): 78-80

Davies, G.; Sinclair, A.J.; Warrington, S.J.; Franklin, R.; Frost, T.; Latham, A.; Robson, P.J. 1982: Pharmacokinetics of meptazinol in man following repeated intramuscular administration. European Journal of Clinical Pharmacology 23(6): 535-538

Bolt, H.M.; Bolt, W.H. 1974: Pharmacokinetics of mestranol in man in relation to its oestrogenic activity. European Journal of Clinical Pharmacology 7(4): 295-305

Sumirtapura, Y.C.; Leroux, Y.; Komar, A.R.; Cano, J.P.; Gaillot, J. 1983: Pharmacokinetics of metapramine (19560 RP) in man after infusion and intravenous injection. European Journal of Clinical Pharmacology 25(5): 673-677

Isnard, F.; Lavieuville, M.; Gut, M. 1980: Pharmacokinetics of metformin. Journees Annuelles de Diabetologie de l'Hotel-Dieu 1980: 305-313

Nilsson, M.I.; Anggård, E.; Holmstrand, J.; Gunne, L.M. 1982: Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase. European Journal of Clinical Pharmacology 22(4): 343-349

Nilsson, M.I.; Grönbladh, L.; Widerlöv, E.; Anggård, E. 1983: Pharmacokinetics of methadone in methadone maintenance treatment: characterization of therapeutic failures. European Journal of Clinical Pharmacology 25(4): 497-501

Gilev, A.P.; Koptelova, M.N.; Shafro, E.A. 1974: Pharmacokinetics of methindion--a new anticonvulsant. Biulleten' Eksperimental'noi Biologii i Meditsiny 78(10): 59-61

Ignoffo, R.J.; Oie, S.; Friedman, M.A. 1981: Pharmacokinetics of methotrexate administered via the hepatic artery. Cancer ChemoTherapy and Pharmacology 5(4): 217-220

Chen, M.L.; Chiou, W.L. 1983: Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration. Journal of Pharmacokinetics and Biopharmaceutics 11(5): 499-513

Breithaupt, H.; Küenzlen, E. 1982: Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate. Cancer Treatment Reports 66(9): 1733-1741

Ettinger, L.J.; Chervinsky, D.S.; Freeman, A.I.; Creaven, P.J. 1982: Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphoma. Cancer 50(9): 1676-1682

Rajeswari, R.; Shetty, P.A.; Gothoskar, B.P.; Akolkar, P.N.; Gokhale, S.V. 1984: Pharmacokinetics of methotrexate in adult Indian patients and its relationship to nutritional status. Cancer Treatment Reports 68(5): 727-732

Long, Q.C.; Pan, Q.C. 1984: Pharmacokinetics of methotrexate in rabbits and six neoplastic patients. Zhongguo Yao Li Xue Bao 5(2): 122-125

George, C.F.; Higgins, V.; Power, K.J.; Renwick, A.G.; Smith, C.L. 1980: Pharmacokinetics of methyldopa in gastrointestinal disease. British Journal of Clinical Pharmacology 9(1): 109P-110P

Myhre, E.; Stenbaek, O.; Rugstad, H.E.; Arnold, E.; Hansen, T. 1982: Pharmacokinetics of methyldopa in renal failure and bilaterally nephrectomized patients. Scandinavian Journal of Urology and Nephrology 16(3): 257-263

Kostyniak, P.J. 1983: Pharmacokinetics of methylmercury in sheep. Journal of Applied Toxicology: Jat 3(1): 35-38

Wargin, W.; Patrick, K.; Kilts, C.; Gualtieri, C.T.; Ellington, K.; Mueller, R.A.; Kraemer, G.; Breese, G.R. 1983: Pharmacokinetics of methylphenidate in man, rat and monkey. Journal of Pharmacology and Experimental Therapeutics 226(2): 382-386

Tornatore, K.M.; Walshe, J.J.; Reed, K.; Venuto, R.C. 1995: Pharmacokinetics of methylprednisolone during acute renal allograft rejection. Clinical Transplantation 9(2): 74-78

Braughler, J.M.; Hall, E.D. 1982: Pharmacokinetics of methylprednisolone in cat plasma and spinal cord following a single intravenous dose of the sodium succinate ester. Drug Metabolism and Disposition: the Biological Fate of Chemicals 10(5): 551-552

Kaufmann, B.; Olcay, A.; Schaumann, W.; Teufel, W.; Weib, W. 1981: Pharmacokinetics of metildigoxin and digoxin in geriatric patients with normal and elevated serum creatinine levels. Clinical Pharmacokinetics 6(6): 463-468

Vergin, H.; Bishop-Freudling, G.B.; Kaiser, W.; Köhler, M.; Strobel, K.; Reutter, F.W. 1983: Pharmacokinetics of metioprim in normal subjects and patients with impaired renal function. Antimicrobial Agents and ChemoTherapy 24(2): 190-193

Abshagen, U.; Betzien, G.; Kaufmann, B.; Endele, G. 1982: Pharmacokinetics of metipranolol in normal man. European Journal of Clinical Pharmacology 21(4): 293-301

Tilstone, W.J.; Dargie, H.; Dargie, E.N.; Morgan, H.G.; Kennedy, A.C. 1974: Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure. Clinical Pharmacology and Therapeutics 16(2): 322-329

Regårdh, C.G.; Landahl, S.; Larsson, M.; Lundborg, P.; Steen, B.; Hoffmann, K.J.; Lagerström, P.O. 1983: Pharmacokinetics of metoprolol and its metabolite alpha-OH-metoprolol in healthy, non-smoking, elderly individuals. European Journal of Clinical Pharmacology 24(2): 221-226

Larsson, M.; Landahl, S.; Lundborg, P.; Regårdh, C.G. 1984: Pharmacokinetics of metoprolol in healthy, elderly, non-smoking individuals after a single dose and two weeks of treatment. European Journal of Clinical Pharmacology 27(2): 217-222

Regårdh, C.G.; Jordö, L.; Ervik, M.; Lundborg, P.; Olsson, R.; Rönn, O. 1981: Pharmacokinetics of metoprolol in patients with hepatic cirrhosis. Clinical Pharmacokinetics 6(5): 375-388

Ludwig, E.; Magyar, T.; Csiba, A.; Kardos, J.; Graber, H. 1981: Pharmacokinetics of metronidazole (Klion) in relation to age. Orvosi Hetilap 122(34): 2093-2095

Bergan, T.; Aase, S.; Leinebo, O.; Harbitz, T.; Olsen, A.; Liavag, I. 1984: Pharmacokinetics of metronidazole and its major metabolite after a high intravenous dose. Scandinavian Journal of Gastroenterology. Supplement 91: 113-123

Easmon, C.S.; Ison, C.A.; Kaye, C.M.; Timewell, R.M.; Dawson, S.G. 1982: Pharmacokinetics of metronidazole and its principal metabolites and their activity against Gardnerella vaginalis. British Journal of Venereal Diseases 58(4): 246-249

Ralph, E.D.; Clarke, J.T.; Libke, R.D.; Luthy, R.P.; Kirby, W.M. 1974: Pharmacokinetics of metronidazole as determined by bioassay. Antimicrobial Agents and ChemoTherapy 6(6): 691-696

Amon, I.; Amon, K.; Zschiesche, M. 1983: Pharmacokinetics of metronidazole during perioperative short-term prophylaxis in cesarean section. Wiener Klinische Wochenschrift 95(16): 562-565

Bergan, T.; Arnold, E. 1980: Pharmacokinetics of metronidazole in healthy adult volunteers after tablets and suppositories. ChemoTherapy 26(4): 231-241

Guay, D.R.; Meatherall, R.C.; Baxter, H.; Jacyk, W.R.; Penner, B. 1984: Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrobial Agents and ChemoTherapy 25(3): 306-310

Cassey, J.G.; Clark, D.A.; Merrick, P.; Jones, B. 1983: Pharmacokinetics of metronidazole in patients undergoing peritoneal dialysis. Antimicrobial Agents and ChemoTherapy 24(6): 950-951

Bergan, T.; Bjerke, P.E.; Fausa, O. 1981: Pharmacokinetics of metronidazole in patients with enteric disease compared to normal volunteers. ChemoTherapy 27(4): 233-238

Baudinet, G.; Henrard, L.; Quinaux, N.; El Allaf, D.; de Landsheere, C.; Carlier, J.; Dresse, A. 1980: Pharmacokinetics of mexiletine in renal insufficiency. Acta Cardiologica. Supplementum 25: 55-65

Thorsteinsson, S.B.; Steingrimsson, O.; Asmundsson, P.; Bergan, T. 1981: Pharmacokinetics of mezlocillin during haemodialysis. Scandinavian Journal of Infectious Diseases. Supplementum 29: 59-63

Bergogne-Berezin, E.; Pierre, J.; Even, P.; Reynaud, P. 1982: Pharmacokinetics of mezlocillin in bronchial secretions. La Nouvelle Presse Medicale 11(5 Part 2): 361-364

Brogard, J.M.; Comte, F.; Spach, M.O.; Lavillaureix, J. 1982: Pharmacokinetics of mezlocillin in patients with kidney impairment: special reference to hemodialysis and dosage adjustments in relation to renal function. ChemoTherapy 28(5): 318-326

Verbist, L.; Tjandramaga, T.B.; Verbesselt, R.; de Schepper, P.J. 1982: Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid. La Nouvelle Presse Medicale 11(5 Part 2): 347-352

Amrein, R.; Cano, J.P.; Eckert, M.; Coassolo, P. 1981: Pharmacokinetics of midazolam after I.v. administration. Arzneimittel-Forschung 31(12a): 2202-2205

Lauven, P.M.; Stoeckel, H.; Ochs, H.; Greenblatt, D.J. 1981: Pharmacokinetics of midazolam in man. Der Anaesthesist 30(6): 280-283

Smith, M.T.; Heazlewood, V.; Eadie, M.J.; Brophy, T.O.; Tyrer, J.H. 1984: Pharmacokinetics of midazolam in the aged. European Journal of Clinical Pharmacology 26(3): 381-388

Mishler, J.M. 1980: Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5. Infusionstherapie und Klinische Ernahrung 7(2): 96-102

Cailleux, A.; Leguay, D.; Wartel, R.; Patay, M.; Allain, P. 1982: Pharmacokinetics of minaprine in human after single oral dose. Therapie 37(1): 45-51

Mather, L.E.; Seow, L.T.; Gourlay, G.K.; Roberts, J.G.; Cousins, M.J. 1980: Pharmacokinetics of minaxolone. British Journal of Anaesthesia 52(2): 241

Fujita, H. 1982: Pharmacokinetics of mitomycin C and its derivative (KW-2083). Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(8): 1362-1373

Smolianskaia, A.Z.; Spasibina, T.V. 1984: Pharmacokinetics of mitomycin C in cancer patients during prolonged administration of the preparation. Antibiotiki 29(5): 391-393

Barbhaiya, R.H.; Papp, E.A.; Van Harken, D.R.; Smyth, R.D. 1984: Pharmacokinetics of mitomycin C in dogs: application of a high-performance liquid chromatographic assay. Journal of Pharmaceutical Sciences 73(9): 1220-1223

Den Hartigh, J.; McVie, J.G.; van Oort, W.J.; Pinedo, H.M. 1983: Pharmacokinetics of mitomycin C in humans. Cancer Research 43(10): 5017-5021

Buice, R.G.; Niell, H.B.; Sidhu, P.; Gurley, B.J. 1984: Pharmacokinetics of mitomycin C in non-oat cell carcinoma of the lung. Cancer ChemoTherapy and Pharmacology 13(1): 1-4

Van Hazel, G.A.; Scott, M.; Rubin, J.; Moertel, C.G.; Eagan, R.T.; O'Connell, M.J.; Kovach, J.S. 1983: Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combination. Cancer Treatment Reports 67(9): 805-810

Van Hazel, G.A.; Kovach, J.S. 1982: Pharmacokinetics of mitomycin C in rabbit and human. Cancer ChemoTherapy and Pharmacology 8(2): 189-192

Gruber, A.; Liliemark, E.; Tidefelt, U.; Paul, C.; Björkholm, M.; Peterson, C.; Liliemark, J. 1995: Pharmacokinetics of mitoxantrone, etoposide and cytosine arabinoside in leukemic cells during treatment of acute myelogenous leukemia--relationship to treatment outcome and bone marrow toxicity. Leukemia Research 19(10): 757-761

Coper, H. 1972: Pharmacokinetics of modern narcotic drugs. Beitrage Zur Gerichtlichen Medizin 29: 144-151

Teschemacher, H. 1973: Pharmacokinetics of morphinan analgesics. Fortschritte der Medizin 91(17): 748

Garrett, E.R.; Gürkan, T. 1980: Pharmacokinetics of morphine and its surrogates IV: Pharmacokinetics of heroin and its derived metabolites in dogs. Journal of Pharmaceutical Sciences 69(10): 1116-1134

Garrett, E.R.; Derendorf, H.; Mattha, A.G. 1985: Pharmacokinetics of morphine and its surrogates. VII: High-performance liquid chromatographic analyses and pharmacokinetics of methadone and its derived metabolites in dogs. Journal of Pharmaceutical Sciences 74(11): 1203-1214

Srinivasan, S.; Fu, K.P.; Neu, H.C. 1981: Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers. Antimicrobial Agents and ChemoTherapy 19(2): 302-305

Humbert, G.; Leroy, A.; Fillastre, J.P. 1983: Pharmacokinetics of moxalactam in adults. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(26): 1963-1967

Kaplan, S.L.; Berry, P.L.; Mason, E.O.; Kramer, W.G. 1983: Pharmacokinetics of moxalactam in anuric children and during hemodialysis. Pediatric Pharmacology 3(1): 29-36

Andritz, M.H.; Smith, R.P.; Baltch, A.L.; Griffin, P.E.; Conroy, J.V.; Sutphen, N.; Hammer, M.C. 1984: Pharmacokinetics of moxalactam in elderly subjects. Antimicrobial Agents and ChemoTherapy 25(1): 33-36

McCracken, G.H.; Schaad, U.B. 1982: Pharmacokinetics of moxalactam in neonates and young infants. Reviews of Infectious Diseases 4 Suppl: S595-S596

Aronoff, G.R.; Sloan, R.S.; Luft, F.C. 1982: Pharmacokinetics of moxalactam in patients with normal and impaired renal function. Journal of Infectious Diseases 145(3): 365-369

Srinivasan, S.; Neu, H.C. 1981: Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis. Antimicrobial Agents and ChemoTherapy 20(3): 398-400

Lam, M.; Manion, C.V.; Czerwinski, A.W. 1981: Pharmacokinetics of moxalactam in patients with renal insufficiency. Antimicrobial Agents and ChemoTherapy 19(3): 461-464

Leroy, A.; Humbert, G.; Fillastre, J.P. 1981: Pharmacokinetics of moxalactam in subjects with normal and impaired renal function. Antimicrobial Agents and ChemoTherapy 19(6): 965-971

Bolton, W.K.; Scheld, W.M.; Spyker, D.A.; Overby, T.L.; Sande, M.A. 1980: Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Antimicrobial Agents and ChemoTherapy 18(6): 933-938

Lode, H.; Warns, H.; Kemmerich, B.; Knothe, H.; Koeppe, P. 1983: Pharmacokinetics of multiple doses of ceftizoxime and their influence on fecal flora. European Journal of Clinical Microbiology 2(2): 116-121

Waser, P.G. 1980: Pharmacokinetics of muscle relaxants. Klinische Anasthesiologie und Intensivtherapie 22: 82-96

Schäfer-Korting, M.; Bach, N.; Knauf, H.; Mutschler, E. 1984: Pharmacokinetics of nadolol in healthy subjects. European Journal of Clinical Pharmacology 26(1): 125-127

Banner, W.; Gooch, W.M.; Burckart, G.; Korones, S.B. 1980: Pharmacokinetics of nafcillin in infants with low birth weights. Antimicrobial Agents and ChemoTherapy 17(4): 691-694

Platt, D.; Mühlberg, W.; Rieck, W.; Horn, H.J.; Schmitt-Rüth, R. 1984: Pharmacokinetics of naftidrofuryl in multimorbidity in geriatric patients. Zeitschrift für Gerontologie 17(5): 246-250

Ferry, N.; Cuisinaud, G.; Sassard, J.; Pozet, N.; Zech, P.Y. 1984: Pharmacokinetics of nalidixic acid associated with sodium citrate. Biopharmaceutics and Drug Disposition 5(3): 211-218

Barbeau, G.; Belanger, P.M. 1982: Pharmacokinetics of nalidixic acid in old and young volunteers. Journal of Clinical Pharmacology 22(10): 490-496

Aarbakke, J.; Gadeholt, G.; Høylandskjaer, A. 1983: Pharmacokinetics of naproxen after oral administration of two tablet formulations in healthy volunteers. International Journal of Clinical Pharmacology Therapy and Toxicology 21(6): 281-283

Calvo, M.V.; Dominguez-Gil, A.; Muriel, C. 1981: Pharmacokinetics of naproxen in patients with hypoproteinemia. International Journal of Clinical Pharmacology Therapy and Toxicology 19(7): 326-330

Anttila, M.; Haataja, M.; Kasanen, A. 1980: Pharmacokinetics of naproxen in subjects with normal and impaired renal function. European Journal of Clinical Pharmacology 18(3): 263-268

Frey, H.H.; Rieh, B. 1981: Pharmacokinetics of naproxen in the dog. American Journal of Veterinary Research 42(9): 1615-1617

Fujita, H.; Ogawa, K.; Okada, A.; Kusama, T.; Kajii, K.; Suga, S.; Kimura, K. 1982: Pharmacokinetics of neothramycin in animals and man. Journal of Antibiotics 35(8): 1093-1100

Michalsen, H.; Bergan, T. 1981: Pharmacokinetics of netilmicin in children with and without cystic fibrosis. Antimicrobial Agents and ChemoTherapy 19(6): 1029-1031

Pliska, V. 1968: Pharmacokinetics of neurohypophysial and related peptides: mathematical models. Il Farmaco; Edizione Scientifica 23(7): 623-641

Komiya, M.; Kikuchi, Y.; Tachibana, A.; Yano, K. 1981: Pharmacokinetics of new broad-spectrum cephamycin, YM09330, parenterally administered to various experimental animals. Antimicrobial Agents and ChemoTherapy 20(2): 176-183

Seth, S.D.; Malhotra, K.K.; Rao, A.; Gupta, M. 1983: Pharmacokinetics of newer combination of sulpha and trimethoprim. Indian Journal of Medical Research 78: 118-125

Graham, D.J.; Dow, R.J.; Freedman, D.; Mroszczak, E.; Ling, T. 1984: Pharmacokinetics of nicardipine following oral and intravenous administration in man. Postgraduate Medical Journal 60(Suppl 4): 7-10

Ishizaki, T.; Chiba, K.; Suganuma, T.; Sasaki, T.; Kamiyama, H.; Nakano, H. 1984: Pharmacokinetics of nicorandil, a new coronary vasodilator, in dogs. Journal of Pharmaceutical Sciences 73(4): 494-498

Rotenberg, K.S.; Adir, J. 1983: Pharmacokinetics of nicotine in rats after multiple-cigarette smoke exposure. Toxicology and Applied Pharmacology 69(1): 1-11

Rotenberg, K.S.; Miller, R.P.; Adir, J. 1980: Pharmacokinetics of nicotine in rats after single-cigarette smoke inhalation. Journal of Pharmaceutical Sciences 69(9): 1087-1090

Maruhn, D.; Siefert, H.M.; Weber, H.; Rämsch, K.; Suwelack, D. 1985: Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey. Arzneimittel-Forschung 35(12): 1781-1786

Yoshimura, M.; Kojima, J.; Ito, T.; Suzuki, J. 1985: Pharmacokinetics of nipradilol (K-351), a new antihypertensive agent. I. Studies on interspecies variation in laboratory animals. Journal of Pharmacobio-Dynamics 8(9): 738-750

Wierzba, K.; Wańkowicz, B.; Prokopczyk, J.; Piekarczyk, A. 1984: Pharmacokinetics of nitrofurantoin in the bodies of pregnant rats. Problemy Medycyny Wieku Rozwojowego 13: 185-192

Fung, H.L.; Ogata, H.; Kamiya, A.; Maier, G.A. 1984: Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat. Journal of Pharmaceutical Sciences 73(7): 873-879

Shaw, J.E. 1984: Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route. American Heart Journal 108(1): 217-223

Fung, H.L. 1983: Pharmacokinetics of nitroglycerin and long-acting nitrate esters. American Journal of Medicine 74(6b): 13-20

Andersson, K.E. 1981: Pharmacokinetics of nitroimidazoles. Spectrum of adverse reactions. Scandinavian Journal of Infectious Diseases. Supplementum 26: 60-67

Russo, R.G.; Cattaneo, M.T.; Bartosek, I. 1984: Pharmacokinetics of nitrosoureas: comparison of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) after oral and intravenous administration to rats. Tumori 70(6): 499-502

Bartosek, I.; Russo, R.G.; Cattaneo, M.T. 1984: Pharmacokinetics of nitrosoureas: levels of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in organs of normal and Walker 256/B carcinoma bearing rats after I.v. bolus. Tumori 70(6): 491-498

McIntyre, I.M.; Norman, T.R.; Burrows, G.D.; Maguire, K.P. 1982: Pharmacokinetics of nomifensine after a single oral dose. British Journal of Clinical Pharmacology 13(5): 740-743

Duvaldestin, P. 1981: Pharmacokinetics of non-depolarizing curare-like drugs. Annales de l'Anesthesiologie Francaise 22(2): 169-171

Singh, H.; Uniyal, J.P.; Jha, P.; Takker, D.; Murguesan, K.; Hingorani, V.; Laumas, K.R. 1982: Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate. Acta Endocrinologica 99(2): 302-308

Yasuda, J.; Fujii, M.; Tsukamoto, K.; Yamamoto, T.; Honjo, H.; Okada, H. 1981: Pharmacokinetics of norethindrone and lynestrenol studied by HPLC. Nihon Naibunpi Gakkai Zasshi 57(8): 1159-1166

Sang, G.W.; Fotherby, K.; Howard, G.; Elder, M.; Bye, P.G. 1981: Pharmacokinetics of norethisterone oenanthate in humans. Contraception 24(1): 15-27

Koch, H.P.; Bykadi, G.; Ledesma, B.; Ritschel, W.A. 1982: Pharmacokinetics of noreximide in the beagle dog. Methods and Findings in Experimental and Clinical Pharmacology 4(8): 587-590

Hughes, P.J.; Webb, D.B.; Asscher, A.W. 1984: Pharmacokinetics of norfloxacin (MK 366) in patients with impaired kidney function--some preliminary results. Journal of Antimicrobial ChemoTherapy 13 Suppl B: 55-57

Eandi, M.; Viano, I.; Di Nola, F.; Leone, L.; Genazzani, E. 1983: Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage. European Journal of Clinical Microbiology 2(3): 253-259

Fillastre, J.P.; Hannedouche, T.; Leroy, A.; Humbert, G. 1984: Pharmacokinetics of norfloxacin in renal failure. Journal of Antimicrobial ChemoTherapy 14(4): 439

Braithwaite, R.A.; Crome, P.; Dawling, S.; Lewis, R.R. 1980: Pharmacokinetics of nortriptyline in elderly depressed patients and prediction of optimal dosage regimes. British Journal of Clinical Pharmacology 9(3): 306P-307P

Hung, S.O.; Patterson, A.; Rees, P.J. 1984: Pharmacokinetics of oral acyclovir (Zovirax) in the eye. British Journal of Ophthalmology 68(3): 192-195

Phillips, T.A.; Howell, A.; Grieve, R.J.; Welling, P.G. 1980: Pharmacokinetics of oral and intravenous fluorouracil in humans. Journal of Pharmaceutical Sciences 69(12): 1428-1431

Bhat, R.; Vidyasagar, D.; Fisher, E.; Hastreiter, A.; Ramirez, J.L.; Burns, L.; Evans, M. 1980: Pharmacokinetics of oral and intravenous indomethacin in preterm infants. Developmental Pharmacology and Therapeutics 1(2-3): 101-110

Bosanquet, A.G.; Gilby, E.D. 1982: Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma. European Journal of Cancer and Clinical Oncology 18(4): 355-362

Jochemsen, R.; Joeres, R.P.; Wesselman, J.G.; Richter, E.; Breimer, D.D. 1983: Pharmacokinetics of oral brotizolam in patients with liver cirrhosis. British Journal of Clinical Pharmacology 16(Suppl 2): 315s-322s

Johnson, C.A.; Welling, P.G.; Zimmerman, S.W. 1984: Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients. Nephron 38(1): 57-61

Kiriwat, O.; Fotherby, K. 1983: Pharmacokinetics of oral contraceptive steroids after morning or evening administration. Contraception 27(2): 153-160

Scherrmann, J.M.; Venet, R.; Memin, Y.; Bourdon, R. 1981: Pharmacokinetics of oral digoxin. Influence of congestive heart failure and age of patients. Therapie 36(2): 169-178

Dresse, A.; Chevolet, C.; Delapierre, D.; Masset, H.; Weisenberger, H.; Bozler, G.; Heinzel, G. 1982: Pharmacokinetics of oral dipyridamole (Persantine) and its effect on platelet adenosine uptake in man. European Journal of Clinical Pharmacology 23(3): 229-234

Johnston, A.; Henry, J.A.; Warrington, S.J.; Hamer, N.A. 1980: Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment. British Journal of Clinical Pharmacology 10(3): 245-248

Hanson, A.; Johansson, B.W.; Wernersson, B.; Wåhlander, L.A. 1983: Pharmacokinetics of oral hydralazine in chronic heart failure. European Journal of Clinical Pharmacology 25(4): 467-473

Volans, G.N.; Jeffereys, D.; Latham, A.N.; Frost, T. 1982: Pharmacokinetics of oral indoramin. Current Medical Research and Opinion 8(1): 51-53

Norbury, H.M.; Franklin, R.A.; Marrott, P.K.; Warrington, S.J. 1984: Pharmacokinetics of oral indoramin in elderly and middle-aged female volunteers. European Journal of Clinical Pharmacology 27(2): 247-249

Balis, F.M.; Savitch, J.L.; Bleyer, W.A. 1983: Pharmacokinetics of oral methotrexate in children. Cancer Research 43(5): 2342-2345

Pentikäinen, P.J.; Halinen, M.O.; Helin, M.J. 1983: Pharmacokinetics of oral mexiletine in patients with acute myocardial infarction. European Journal of Clinical Pharmacology 25(6): 773-777

Kölle, E.U. 1981: Pharmacokinetics of oral prazepam. Fortschritte der Medizin 99(22): 874-879

Lowenthal, D.T.; Briggs, W.A.; Gibson, T.P.; Nelson, H.; Cirksena, W.J. 1974: Pharmacokinetics of oral propranolol in chronic renal disease. Clinical Pharmacology and Therapeutics 16(5 Part 1): 761-769

Albin, H.; Vinçon, G.; Bézier, M.; Pehourcq, F.; Cabanieu, G. 1983: Pharmacokinetics of oral theophylline in asthmatic patients on long-term corticoid therapy. Therapie 38(4): 333-339

Fourtillan, J.B.; Courtois, P.; Lefebvre, M.A.; Girault, J. 1981: Pharmacokinetics of oral timolol studied by mass fragmentography. European Journal of Clinical Pharmacology 19(3): 193-196

Albert, K.S.; Sedman, A.J.; Wagner, J.G. 1974: Pharmacokinetics of orally administered acetaminophen in man. Journal of Pharmacokinetics and Biopharmaceutics 2(5): 381-393

Van Dyke, R.B.; Connor, J.D.; Wyborny, C.; Hintz, M.; Keeney, R.E. 1982: Pharmacokinetics of orally administered acyclovir in patients with herpes progenitalis. American Journal of Medicine 73(1a): 172-175

Kelly, M.R.; Cutler, R.E.; Forrey, A.W.; Kimpel, B.M. 1974: Pharmacokinetics of orally administered furosemide. Clinical Pharmacology and Therapeutics 15(2): 178-186

Prandota, J. 1982: Pharmacokinetics of orally administered furosemide in children with nephrotic syndrome. Pediatria Polska 57(9): 711-718

Merdjan, H.; Singlas, E.; Baumelou, A.; Perez, M.; Chick, O. 1983: Pharmacokinetics of ornidazole in the patient with renal failure; influence of hemodialysis and peritoneal dialysis. Presse Medicale 12(21): 1367

Dittrich, P.; Ferber, H.; Vergin, H.; Kukovetz, W.R. 1981: Pharmacokinetics of oxametacin in healthy volunteers following multiple administration. Arzneimittel-Forschung 31(3): 518-523

Busch, U.; Molzahn, M.; Bozler, G.; Koss, F.W. 1981: Pharmacokinetics of oxazepam following multiple administration in volunteers and patients with chronic renal disease. Arzneimittel-Forschung 31(9): 1507-1511

Marriner, S.E.; Bogan, J.A. 1981: Pharmacokinetics of oxfendazole in sheep. American Journal of Veterinary Research 42(7): 1143-1145

Li, L.; Zhao, D. 1995: Pharmacokinetics of oximes in organophosphorus poison. Zhonghua Nei Ke Za Zhi 34(2): 136-138

Jönsson, K.A.; Bodemar, G.; Gotthard, R.; Norlander, B.; Walan, A. 1983: Pharmacokinetics of oxmetidine, a new histamine H2-receptor antagonist, after single oral and intravenous doses. European Journal of Clinical Pharmacology 24(3): 353-356

Kendall, M.J. 1983: Pharmacokinetics of oxprenolol in the elderly. American Journal of Cardiology 52(9): 54D-56D

Schifferli, D.; Galeazzi, R.L.; Nicolet, J.; Wanner, M. 1982: Pharmacokinetics of oxytetracycline and therapeutic implications in veal calves. Journal of Veterinary Pharmacology and Therapeutics 5(4): 247-257

Leake, R.D.; Weitzman, R.E.; Fisher, D.A. 1980: Pharmacokinetics of oxytocin in the human subject. Obstetrics and Gynecology 56(6): 701-704

Nanbo, T. 1983: Pharmacokinetics of p-phenylbenzoic acid in near-term fetus of the rat. Chemical and Pharmaceutical Bulletin 31(10): 3748-3751

Duvaldestin, P.; Demetriou, M.; D'Hollander, A. 1982: Pharmacokinetics of pancuronium in man: a linear system. European Journal of Clinical Pharmacology 23(4): 369-372

Wójcicki, J.; Gawrońska-Szklarz, B. 1984: Pharmacokinetics of paracetamol in patients with gastric and duodenal ulcers. Polish Journal of Pharmacology and Pharmacy 36(1): 59-63

Autret, E.; Dutertre, J.P.; Breteau, M.; Jonville, A.P.; Furet, Y.; Laugier, J. 1993: Pharmacokinetics of paracetamol in the neonate and infant after administration of propacetamol chlorhydrate. Developmental Pharmacology and Therapeutics 20(3-4): 129-134

Giacoia, G.P.; Gessner, P.K.; Zaleska, M.M.; Boutwell, W.C. 1984: Pharmacokinetics of paraldehyde disposition in the neonate. Journal of Pediatrics 104(2): 291-296

Borgström, L.; Larsson, H.; Molander, L. 1982: Pharmacokinetics of parenteral and oral melperone in man. European Journal of Clinical Pharmacology 23(2): 173-176

Sisenwine, S.F.; Tio, C.O.; Liu, A.L.; Ruelius, H.W. 1982: Pharmacokinetics of parenteral dezocine in rhesus monkeys and dogs. Drug Metabolism and Disposition: the Biological Fate of Chemicals 10(4): 366-370

Seymour, R.A.; Rawlins, M.D. 1981: Pharmacokinetics of parenteral paracetamol and its analgesic effects in post-operative dental pain. European Journal of Clinical Pharmacology 20(3): 215-218

Regamey, C.; Libke, R.D.; Clarke, J.T.; Kirby, W.M. 1974: Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin. Infection 2(3): 132-136

Hill, S.A.; Jones, K.H.; Lees, L.J. 1980: Pharmacokinetics of parenterally administered amoxycillin. Journal of Infection 2(4): 320-332

Simon, C.; Bekesch, M.; Malerczyk, V. 1972: Pharmacokinetics of penicillin V in childhood (especially in newborn infants). Die Medizinische Welt 23(46): 1717-1720

Nurazian, A.G.; Sukiasian, A.O.; Abramian, V.R.; Martirosian, A.O.; Badeian, A.A. 1974: Pharmacokinetics of penicillin in the body of pregnant rabbits and their fetuses. Akusherstvo i Ginekologiia 11: 69-70

Iakovlev, V.P.; Bobrov, V.I.; Agapitova, I.V.; Nazarova, O.I.; Solianik, G.I. 1983: Pharmacokinetics of penicillins following combined administration with sulfanilamides. Antibiotiki 28(6): 424-429

Geitman, I.I.; Kivman, G.I.; Kalinina, N.A.; Balyn', I.R.; Butylina, L.V. 1974: Pharmacokinetics of penicillins in the body of rats, including penetration into a granuloma, with repeated administration of the antibiotics and chymotrysin. Antibiotiki 19(11): 1012-1017

Pittman, K.A.; Portmann, G.A. 1974: Pharmacokinetics of pentazocine in the rhesus monkey. Journal of Pharmaceutical Sciences 63(1): 84-88

Alvarez, R.A. 1971: Pharmacokinetics of pentobarbital and thiopental in the isolated perfused rat liver. Archives Internationales de Pharmacodynamie et de Therapie 189(2): 380

Frederiksen, M.C.; Henthorn, T.K.; Ruo, T.I.; Atkinson, A.J. 1983: Pharmacokinetics of pentobarbital in the dog. Journal of Pharmacology and Experimental Therapeutics 225(2): 355-360

Kramer, W.G.; Welch, D.W.; Fife, W.P.; Chaikin, B.N.; Medlock, C.; Gross, D.R. 1983: Pharmacokinetics of pentobarbital under hyperbaric and hyperbaric hyperoxic conditions in the dog. Aviation Space and Environmental Medicine 54(11): 1005-1008

Prince, J.R.; Bancroft, S.; Dukstein, W.G. 1980: Pharmacokinetics of pertechnetate administered after pretreatment with 400 mg of potassium perchlorate: concise communication. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 21(8): 763-766

Hartvig, P.; Tamsen, A.; Fagerlund, C.; Dahlström, B. 1982: Pharmacokinetics of pethidine during anaesthesia and patient-controlled analgesic therapy. Acta Anaesthesiologica Scandinavica. Supplementum 74: 52-54

Orzechowska-Juzwenko, K.; Bolanowski, M.; Gruszka, S.; Szymczak, J. 1983: Pharmacokinetics of phenazone as an indicator of the metabolic capacity of the liver in patients with hyperthyroidism. Polski Tygodnik Lekarski 38(20-21): 643-645

Iven, H.; Feldbusch, E. 1983: Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse. Naunyn-Schmiedeberg's Archives of Pharmacology 324(2): 153-159

Peiker, G.; Traeger, A. 1974: Pharmacokinetics of phenobarbital in pregnancy. Zentralblatt für Gynakologie 96(19): 577-582

Josefsson, K.; Bergan, T. 1982: Pharmacokinetics of phenoxymethylpenicillin in volunteers. ChemoTherapy 28(4): 241-246

Heni, N.; Lenhardt, G.; Glogner, P. 1974: Pharmacokinetics of phenprocoumon (Marcumar) in patients with liver cirrhosis and following induction treatment with phenobarbital. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 1475-1477

Gerring, E.L.; Lees, P.; Taylor, J.B. 1981: Pharmacokinetics of phenylbutazone and its metabolites in the horse. Equine Veterinary Journal 13(3): 152-157

Sioufi, A.; Colussi, D.; Caudal, F.; Schoeller, J.P.; Massias, P. 1980: Pharmacokinetics of phenylbutazone in healthy subjects after oral administration of single and multiple doses. Journal of Pharmaceutical Sciences 69(12): 1413-1416

Pisani, F.; Richens, A. 1983: Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration. Clinical Pharmacokinetics 8(3): 272-276

Cottrell, P.R.; Streete, J.M.; Berry, D.J.; Schäfer, H.; Pisani, F.; Perucca, E.; Richens, A. 1982: Pharmacokinetics of phenylethylmalonamide (PEMA) in normal subjects and in patients treated with antiepileptic drugs. Epilepsia 23(3): 307-313

Kowalczyk, D.F.; Beech, J. 1983: Pharmacokinetics of phenytoin (diphenylhydantoin) in horses. Journal of Veterinary Pharmacology and Therapeutics 6(2): 133-140

Blain, P.G.; Mucklow, J.C.; Bacon, C.J.; Rawlins, M.D. 1981: Pharmacokinetics of phenytoin in children. British Journal of Clinical Pharmacology 12(5): 659-661

Hess, B.; Keusch, G.; Flückiger, J.; Binswanger, U. 1984: Pharmacokinetics of phenytoin in continuous ambulatory peritoneal dialysis. 2 cases and brief review of the literature. Schweizerische Medizinische Wochenschrift 114(1): 16-19

Fernandez Lastra, C.; Mariño, E.L.; Dominguez-Gil, A.; Tabernero, J.M.; Grande Villoria, J. 1984: Pharmacokinetics of phosphomycin during haemofiltration. British Journal of Clinical Pharmacology 17(4): 477-480

Kwan, K.C.; Wadke, D.A.; Foltz, E.L. 1971: Pharmacokinetics of phosphonomycin in Man. I. Intravenous administration. Journal of Pharmaceutical Sciences 60(5): 678-685

Pacifici, G.M.; Placidi, G.F.; Fornaro, P.; Gomeni, R. 1983: Pharmacokinetics of pinazepam in healthy volunteers. International Journal of Clinical Pharmacology Research 3(5): 331-337

Juma, F.D. 1983: Pharmacokinetics of pindolol in Kenyan Africans. European Journal of Clinical Pharmacology 25(3): 425-426

Salathé, B.; Kerle, F.H. 1980: Pharmacokinetics of pindolol in a group of elderly hypertensive patients. Aktuelle Gerontologie 10(10): 443-447

Schwarz, H.J. 1982: Pharmacokinetics of pindolol in humans and several animal species. American Heart Journal 104(2 Part 2): 357-364

Bodrogi, L.; Fehér, T.; Váradi, A.; Vereczkey, L. 1980: Pharmacokinetics of pipecurium bromide in the rat. Arzneimittel-Forschung 30(2a): 366-370

Tassonyi, E.; Szabó, G.; Vereczkey, L. 1981: Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans. Arzneimittel-Forschung 31(10): 1754-1756

Männistö, P.; Solkinen, A.; Mäntylä, R.; Gordin, A.; Salo, H.; Hänninen, U.; Niinistö, L. 1984: Pharmacokinetics of pipemidic acid in healthy middle-aged volunteers and elderly patients with renal insufficiency. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 14(4): 339-347

Batra, V.K.; Morrison, J.A.; Hoffman, T.R. 1983: Pharmacokinetics of piperacillin and gentamicin following intravenous administration to dogs. Journal of Pharmaceutical Sciences 72(8): 894-898

Giron, J.A.; Meyers, B.R.; Hirschman, S.Z.; Srulevitch, E. 1981: Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis. Antimicrobial Agents and ChemoTherapy 19(2): 279-283

George, C.R.; Burgoyne, J.; Funnell, G.R.; Robinson, P.; Collignon, P.; Meads, K.; Guinness, M.D. 1981: Pharmacokinetics of piperacillin in renal failure. Medical Journal of Australia 1(1): 35-36

Welling, P.G.; Craig, W.A.; Bundtzen, R.W.; Kwok, F.W.; Gerber, A.U.; Madsen, P.O. 1983: Pharmacokinetics of piperacillin in subjects with various degrees of renal function. Antimicrobial Agents and ChemoTherapy 23(6): 881-887

Hobbs, D.C. 1983: Pharmacokinetics of piroxicam in man. European Journal of Rheumatology and Inflammation 6(1): 46-55

Loo, J.C.; Foltz, E.L.; Wallick, H.; Kwan, K.C. 1974: Pharmacokinetics of pivampicillin and ampicillin in man. Clinical Pharmacology and Therapeutics 16(1): 35-43

Ziv, G.; Schultze, W.D. 1982: Pharmacokinetics of polymyxin B administered via the bovine mammary gland. Journal of Veterinary Pharmacology and Therapeutics 5(2): 123-129

Diksic, M.; Sako, K.; Feindel, W.; Kato, A.; Yamamoto, Y.L.; Farrokhzad, S.; Thompson, C. 1984: Pharmacokinetics of positron-labeled 1,3-bis(2-chloroethyl)nitrosourea in human brain tumors using positron emission tomography. Cancer Research 44(7): 3120-3124

Kaumeier, S.; Kisslinger, E.; Neiss, A. 1980: Pharmacokinetics of potassium ampicillin. Arzneimittel-Forschung 30(6): 1019-1021

Nelson, J.D.; Kusmiesz, H.; Shelton, S. 1982: Pharmacokinetics of potassium clavulanate in combination with amoxicillin in pediatric patients. Antimicrobial Agents and ChemoTherapy 21(4): 681-682

Dynon, M.K.; Jarrott, B.; Drummer, O.; Louis, W.J. 1980: Pharmacokinetics of prazosin in normotensive subjects after low oral doses. Clinical Pharmacokinetics 5(6): 583-590

Von Papen, C.; Benker, G.; Hackenberg, K.; Reinwein, D. 1982: Pharmacokinetics of prednisolone in adrenal insufficiency. Klinische Wochenschrift 60(13): 681-686

McAllister, W.A.; Winfield, C.R.; Collins, J.V. 1981: Pharmacokinetics of prednisolone in normal and asthmatic subjects in relation to dose. European Journal of Clinical Pharmacology 20(2): 141-145

Gatti, G.; Perucca, E.; Frigo, G.M.; Notarangelo, L.D.; Barberis, L.; Martini, A. 1984: Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission. British Journal of Clinical Pharmacology 17(4): 423-431

Rönn, O. 1982: Pharmacokinetics of prenalterol in healthy subjects and patients with congestive heart failure. Acta Medica Scandinavica. Supplementum 659: 89-98

Tiurin, N.A.; Kotlukov, V.K.; Buzovskiĭ, A.N. 1983: Pharmacokinetics of preparations of eufilin in children with bronchial asthma. Pediatriia 4: 33-35

Noguchi, H.; Tokuma, Y.; Tamura, Y. 1983: Pharmacokinetics of prifinium bromide in healthy volunteers. International Journal of Clinical Pharmacology Therapy and Toxicology 21(5): 213-217

Mihaly, G.W.; Ward, S.A.; Edwards, G.; Orme, M.L.; Breckenridge, A.M. 1984: Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. British Journal of Clinical Pharmacology 17(4): 441-446

Lee, C.S.; Marbury, T.C.; Perchalski, R.T.; Wilder, B.J. 1982: Pharmacokinetics of primidone elimination by uremic patients. Journal of Clinical Pharmacology 22(7): 301-308

Selen, A.; Amidon, G.L.; Welling, P.G. 1982: Pharmacokinetics of probenecid following oral doses to human volunteers. Journal of Pharmaceutical Sciences 71(11): 1238-1242

Weily, H.S.; Genton, E. 1972: Pharmacokinetics of procainamide. Archives of Internal Medicine 130(3): 366-369

Kamath, B.L.; Lai, C.M.; Gupta, S.D.; Durrani, M.J.; Yacobi, A. 1981: Pharmacokinetics of procainamide and N-acetylprocainamide in rats. Journal of Pharmaceutical Sciences 70(3): 299-302

Basseches, P.J.; DiGregorio, G.J. 1982: Pharmacokinetics of procainamide in rats with extrahepatic biliary obstruction. Journal of Pharmaceutical Sciences 71(11): 1256-1259

Anand Kumar, T.C.; David, G.F.; Sankaranarayanan, A.; Puri, V.; Sundram, K.R. 1982: Pharmacokinetics of progesterone after its administration to ovariectomized rhesus monkeys by injection, infusion, or nasal spraying. Proceedings of the National Academy of Sciences of the United States of America 79(13): 4185-4189

Johnson, A.L.; van Tienhoven, A. 1981: Pharmacokinetics of progesterone in laying and non-laying hens (Gallus domesticus). Journal of Endocrinology 89(1): 1-12

Hu, O.Y.; Tang, H.S.; Sheeng, T.Y.; Chen, T.C.; Curry, S.H. 1995: Pharmacokinetics of promazine in patients with hepatic cirrhosis--correlation with a novel galactose single point method. Journal of Pharmaceutical Sciences 84(1): 111-114

Taylor, G.; Houston, J.B.; Shaffer, J.; Mawer, G. 1983: Pharmacokinetics of promethazine and its sulphoxide metabolite after intravenous and oral administration to man. British Journal of Clinical Pharmacology 15(3): 287-293

Pearson, R.M. 1984: Pharmacokinetics of propoxyphene. Human Toxicology 3 Suppl: 37s-40s

Borgström, L.; Johansson, C.G.; Larsson, H.; Lenander, R. 1981: Pharmacokinetics of propranolol. Journal of Pharmacokinetics and Biopharmaceutics 9(4): 419-429

Aro, A.; Anttila, M.; Korhonen, T.; Sundquist, H. 1982: Pharmacokinetics of propranolol and sotalol in hyperthyroidism. European Journal of Clinical Pharmacology 21(5): 373-377

Steinhoff, J.; Migulla, H.; Buhr, N.; Wrobel, J. 1981: Pharmacokinetics of propranolol in healthy humans. Die Pharmazie 36(11): 785-786

Kawashima, K.; Ishikawa, H. 1980: Pharmacokinetics of propranolol isomers and their relationships with beta adrenoceptor blocking activity in rabbits administered with dl-propranolol. Journal of Pharmacology and Experimental Therapeutics 213(3): 628-631

Lou, Y.Q. 1981: Pharmacokinetics of propranolol, the beta-adrenergic receptor blocking agents. Sheng Li Ke Xue Jin Zhan 12(2): 167-170

Okuno, A.; Taguchi, T.; Inyaku, F.; Yano, K.; Suzuki, Y. 1983: Pharmacokinetics of propylthiouracil in children and adolescents with Graves disease after a single oral dose. Pediatric Pharmacology 3(1): 43-47

Ringhand, H.P.; Ritschel, W.A.; Meyer, M.C.; Straughn, A.B.; Hardt, T. 1980: Pharmacokinetics of propylthiouracil upon p.o. administration in man. International Journal of Clinical Pharmacology Therapy and Toxicology 18(11): 488-493

Weiss, M.; Förster, W. 1980: Pharmacokinetics of prostaglandins: prediction of steady-state concentrations during intravenous infusion. International Journal of Clinical Pharmacology Therapy and Toxicology 18(8): 344-347

Selvig, K. 1981: Pharmacokinetics of proxyphylline in adults after intravenous and oral administration. European Journal of Clinical Pharmacology 19(2): 149-155

Löscher, W.; Reiche, R. 1983: Pharmacokinetics of psychotropic drugs in domestic animals. Deutsche Tierärztliche Wochenschrift 90(2): 52-59

Vandel, B.; Bonin, B.; Vandel, S. 1982: Pharmacokinetics of psychotropic drugs: importance in psychiatric practice. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 58(44): 2597-2605

Hrdina, P.D.; Hutchinson, L.J.; Lapierre, Y.D.; Perel, J.M.; Reed, K.L. 1982: Pharmacokinetics of psychotropic drugs: what can it tell us?. Progress in Neuro-Psychopharmacology and Biological Psychiatry 6(4-6): 681-688

Hsiang, C.S.; Yang, Y.L.; Zhang, W.G.; Zhu, X.Y. 1981: Pharmacokinetics of puerarin - determination of its plasma concentration by spectrofluorometry. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 3(Suppl 1): 48-51